# Vertex Pharmaceuticals timeline entity: /record/vertex-pharmaceuticals.md id: ent_vertex-pharmaceuticals Vertex Pharmaceuticals' timeline holds 545 money & deals claims from 2007 to 2026. The latest took effect on October 31, 2026. Kinds: People 0 (/timelines/vertex-pharmaceuticals.md?kind=people) · Money & deals 545 (/timelines/vertex-pharmaceuticals.md?kind=money) · Products 0 (/timelines/vertex-pharmaceuticals.md?kind=products) · Models 0 (/timelines/vertex-pharmaceuticals.md?kind=models) · Other 8 (/timelines/vertex-pharmaceuticals.md?kind=other) · every kind: /timelines/vertex-pharmaceuticals.md Format: date | kind | predicate | value | status | claim. ## 2007 - 2007-12-31 to 2008-12-31 | money | cash_and_equivalents | 355,663,000 United States dollar | superseded | [clm_95E62B146772](/claim/clm_95E62B146772.md) - 2007-12-31 to 2008-12-31 | money | total_equity | 271,295,000 United States dollar | superseded | [clm_ACFA9A6B78BD](/claim/clm_ACFA9A6B78BD.md) ## 2008 - 2008-12-31 to 2009-03-31 | money | cash_and_equivalents | 389,115,000 United States dollar | superseded | [clm_FAD35E124DA4](/claim/clm_FAD35E124DA4.md) - 2008-12-31 to 2009-12-31 | money | operating_income | -462,708,000 United States dollar | superseded | [clm_FEC47F071AB0](/claim/clm_FEC47F071AB0.md) - 2008-12-31 to 2009-12-31 | money | research_and_development | 516,912,000 United States dollar | superseded | [clm_9DFE9C7313E6](/claim/clm_9DFE9C7313E6.md) - 2008-12-31 to 2009-12-31 | money | revenue | 175,504,000 United States dollar | superseded | [clm_3F47912035B4](/claim/clm_3F47912035B4.md) - 2008-12-31 to 2009-12-31 | money | total_equity | 238,874,000 United States dollar | superseded | [clm_393679081B64](/claim/clm_393679081B64.md) ## 2009 - 2009-03-31 to 2009-06-30 | money | cash_and_equivalents | 602,199,000 United States dollar | superseded | [clm_DAD4C578295B](/claim/clm_DAD4C578295B.md) - 2009-03-31 to 2009-06-30 | money | quarterly_operating_income | -161,893,000 United States dollar | superseded | [clm_ADBE4057ECC4](/claim/clm_ADBE4057ECC4.md) - 2009-03-31 to 2009-06-30 | money | quarterly_research_and_development | 143,581,000 United States dollar | superseded | [clm_BEF2FDEB0A7D](/claim/clm_BEF2FDEB0A7D.md) - 2009-03-31 to 2009-06-30 | money | quarterly_revenue | 23,979,000 United States dollar | superseded | [clm_8EDF57286E75](/claim/clm_8EDF57286E75.md) - 2009-06-30 to 2009-09-30 | money | cash_and_equivalents | 408,949,000 United States dollar | superseded | [clm_2E63C80C1EC9](/claim/clm_2E63C80C1EC9.md) - 2009-06-30 to 2009-09-30 | money | quarterly_operating_income | -157,167,000 United States dollar | superseded | [clm_21238AD57FDF](/claim/clm_21238AD57FDF.md) - 2009-06-30 to 2009-09-30 | money | quarterly_research_and_development | 139,331,000 United States dollar | superseded | [clm_807DBFE23E9F](/claim/clm_807DBFE23E9F.md) - 2009-06-30 to 2009-09-30 | money | quarterly_revenue | 19,064,000 United States dollar | superseded | [clm_8CAD8C9EBAFE](/claim/clm_8CAD8C9EBAFE.md) - 2009-09-30 to 2009-12-31 | money | cash_and_equivalents | 559,133,000 United States dollar | superseded | [clm_F77D600A24ED](/claim/clm_F77D600A24ED.md) - 2009-09-30 to 2010-03-31 | money | quarterly_operating_income | -148,233,000 United States dollar | superseded | [clm_CD892C0A824B](/claim/clm_CD892C0A824B.md) - 2009-09-30 to 2010-03-31 | money | quarterly_research_and_development | 132,132,000 United States dollar | superseded | [clm_E5A0F7F2EB85](/claim/clm_E5A0F7F2EB85.md) - 2009-09-30 to 2010-03-31 | money | quarterly_revenue | 24,957,000 United States dollar | superseded | [clm_FCBA634A768D](/claim/clm_FCBA634A768D.md) - 2009-12-31 to 2010-03-31 | money | cash_and_equivalents | 446,658,000 United States dollar | superseded | [clm_0B1A1540D1B7](/claim/clm_0B1A1540D1B7.md) - 2009-12-31 to 2010-12-31 | money | net_income | -642,178,000 United States dollar | superseded | [clm_25D63D0ED4EF](/claim/clm_25D63D0ED4EF.md) - 2009-12-31 to 2010-12-31 | money | operating_income | -614,012,000 United States dollar | superseded | [clm_9AF280BB8EE3](/claim/clm_9AF280BB8EE3.md) - 2009-12-31 to 2010-12-31 | money | research_and_development | 550,274,000 United States dollar | superseded | [clm_7210AEE2240D](/claim/clm_7210AEE2240D.md) - 2009-12-31 to 2010-12-31 | money | revenue | 101,889,000 United States dollar | superseded | [clm_72998EF97E5B](/claim/clm_72998EF97E5B.md) - 2009-12-31 to 2010-03-31 | money | total_assets | 1,955,488,000 United States dollar | superseded | [clm_4369373195D9](/claim/clm_4369373195D9.md) - 2009-12-31 to 2010-03-31 | money | total_equity | 1,096,346,000 United States dollar | superseded | [clm_9E65725B61EB](/claim/clm_9E65725B61EB.md) ## 2010 - 2010-03-31 to 2010-06-30 | money | cash_and_equivalents | 396,547,000 United States dollar | superseded | [clm_704DCF1A9448](/claim/clm_704DCF1A9448.md) - 2010-03-31 to 2010-06-30 | money | quarterly_operating_income | -160,282,000 United States dollar | superseded | [clm_6F9D9EB7890A](/claim/clm_6F9D9EB7890A.md) - 2010-03-31 to 2010-06-30 | money | quarterly_research_and_development | 143,012,000 United States dollar | superseded | [clm_D2BF7F6D2E9B](/claim/clm_D2BF7F6D2E9B.md) - 2010-03-31 to 2010-06-30 | money | quarterly_revenue | 22,429,000 United States dollar | superseded | [clm_803A751AACB0](/claim/clm_803A751AACB0.md) - 2010-03-31 to 2010-06-30 | money | total_assets | 1,770,302,000 United States dollar | superseded | [clm_71D593846901](/claim/clm_71D593846901.md) - 2010-03-31 to 2010-06-30 | money | total_equity | 990,612,000 United States dollar | superseded | [clm_19213C00D007](/claim/clm_19213C00D007.md) - 2010-04-22 to 2010-07-29 | money | shares_outstanding | 202,202,912 shares | superseded | [clm_5547C6BF3A52](/claim/clm_5547C6BF3A52.md) - 2010-06-30 to 2010-09-30 | money | cash_and_equivalents | 337,608,000 United States dollar | superseded | [clm_FFDB6607C3CE](/claim/clm_FFDB6607C3CE.md) - 2010-06-30 to 2010-09-30 | money | quarterly_net_income | -200,006,000 United States dollar | superseded | [clm_8F60B25A1E7E](/claim/clm_8F60B25A1E7E.md) - 2010-06-30 to 2010-09-30 | money | quarterly_operating_income | -169,573,000 United States dollar | superseded | [clm_66CCBB904B9A](/claim/clm_66CCBB904B9A.md) - 2010-06-30 to 2010-09-30 | money | quarterly_research_and_development | 155,082,000 United States dollar | superseded | [clm_A76FEE254CA5](/claim/clm_A76FEE254CA5.md) - 2010-06-30 to 2010-09-30 | money | quarterly_revenue | 31,622,000 United States dollar | superseded | [clm_91E848597DF5](/claim/clm_91E848597DF5.md) - 2010-06-30 to 2010-09-30 | money | total_assets | 1,654,202,000 United States dollar | superseded | [clm_5B82DB4B1ACF](/claim/clm_5B82DB4B1ACF.md) - 2010-06-30 to 2010-09-30 | money | total_equity | 827,135,000 United States dollar | superseded | [clm_0E4918D23EC7](/claim/clm_0E4918D23EC7.md) - 2010-07-29 to 2010-10-21 | money | shares_outstanding | 202,831,612 shares | superseded | [clm_115794095037](/claim/clm_115794095037.md) - 2010-09-30 to 2010-12-31 | money | cash_and_equivalents | 569,901,000 United States dollar | superseded | [clm_99FB6CAA75AD](/claim/clm_99FB6CAA75AD.md) - 2010-09-30 to 2011-03-31 | money | quarterly_net_income | -208,957,000 United States dollar | superseded | [clm_185D3E640F90](/claim/clm_185D3E640F90.md) - 2010-09-30 to 2011-03-31 | money | quarterly_operating_income | -199,588,000 United States dollar | superseded | [clm_8982B813454B](/claim/clm_8982B813454B.md) - 2010-09-30 to 2011-03-31 | money | quarterly_research_and_development | 170,434,000 United States dollar | superseded | [clm_D6506FFCBC0C](/claim/clm_D6506FFCBC0C.md) - 2010-09-30 to 2011-03-31 | money | quarterly_revenue | 23,795,000 United States dollar | superseded | [clm_A2ABBC5D4946](/claim/clm_A2ABBC5D4946.md) - 2010-09-30 to 2010-12-31 | money | total_assets | 1,888,829,000 United States dollar | superseded | [clm_C3D8BF48EB7E](/claim/clm_C3D8BF48EB7E.md) - 2010-09-30 to 2010-12-31 | money | total_equity | 650,096,000 United States dollar | superseded | [clm_6AC662175277](/claim/clm_6AC662175277.md) - 2010-10-21 to 2011-02-09 | money | shares_outstanding | 203,194,222 shares | superseded | [clm_69DF2085CFCB](/claim/clm_69DF2085CFCB.md) - 2010-12-31 to 2011-03-31 | money | cash_and_equivalents | 243,197,000 United States dollar | superseded | [clm_6F397338265E](/claim/clm_6F397338265E.md) - 2010-12-31 to 2011-12-31 | money | net_income | -754,626,000 United States dollar | superseded | [clm_6694DF685051](/claim/clm_6694DF685051.md) - 2010-12-31 to 2011-12-31 | money | operating_income | -696,077,000 United States dollar | superseded | [clm_9472043EC2FF](/claim/clm_9472043EC2FF.md) - 2010-12-31 to 2011-12-31 | money | research_and_development | 637,416,000 United States dollar | superseded | [clm_7AB4898F104F](/claim/clm_7AB4898F104F.md) - 2010-12-31 to 2011-12-31 | money | revenue | 143,370,000 United States dollar | superseded | [clm_A50C566EACEB](/claim/clm_A50C566EACEB.md) - 2010-12-31 to 2011-03-31 | money | total_assets | 1,725,446,000 United States dollar | superseded | [clm_CE17430C757C](/claim/clm_CE17430C757C.md) - 2010-12-31 to 2011-03-31 | money | total_equity | 503,973,000 United States dollar | superseded | [clm_ABDC2E967578](/claim/clm_ABDC2E967578.md) ## 2011 - 2011-02-09 to 2011-04-28 | money | shares_outstanding | 204,412,712 shares | superseded | [clm_995698503836](/claim/clm_995698503836.md) - 2011-03-31 to 2011-06-30 | money | cash_and_equivalents | 446,536,000 United States dollar | superseded | [clm_F97987974B05](/claim/clm_F97987974B05.md) - 2011-03-31 to 2011-06-30 | money | quarterly_net_income | -176,096,000 United States dollar | superseded | [clm_ECF62E043F01](/claim/clm_ECF62E043F01.md) - 2011-03-31 to 2011-06-30 | money | quarterly_operating_income | -159,899,000 United States dollar | superseded | [clm_EF4EBE9A383C](/claim/clm_EF4EBE9A383C.md) - 2011-03-31 to 2011-06-30 | money | quarterly_research_and_development | 158,612,000 United States dollar | superseded | [clm_35956A6601A7](/claim/clm_35956A6601A7.md) - 2011-03-31 to 2011-06-30 | money | quarterly_revenue | 73,662,000 United States dollar | superseded | [clm_06E54341B7F1](/claim/clm_06E54341B7F1.md) - 2011-03-31 to 2011-06-30 | money | total_assets | 1,538,487,000 United States dollar | superseded | [clm_DBCB7DA025BF](/claim/clm_DBCB7DA025BF.md) - 2011-03-31 to 2011-06-30 | money | total_equity | 391,672,000 United States dollar | superseded | [clm_6FF0398AE57E](/claim/clm_6FF0398AE57E.md) - 2011-04-28 to 2011-07-29 | money | shares_outstanding | 205,997,844 shares | superseded | [clm_AFEA9E22E536](/claim/clm_AFEA9E22E536.md) - 2011-06-30 to 2011-09-30 | money | cash_and_equivalents | 458,195,000 United States dollar | superseded | [clm_0816B23FB77A](/claim/clm_0816B23FB77A.md) - 2011-06-30 to 2011-09-30 | money | quarterly_net_income | -174,069,000 United States dollar | superseded | [clm_46C52FB158CE](/claim/clm_46C52FB158CE.md) - 2011-06-30 to 2011-09-30 | money | quarterly_operating_income | -165,890,000 United States dollar | superseded | [clm_D1B891CE165A](/claim/clm_D1B891CE165A.md) - 2011-06-30 to 2011-09-30 | money | quarterly_research_and_development | 173,604,000 United States dollar | superseded | [clm_B5FD1F0507D0](/claim/clm_B5FD1F0507D0.md) - 2011-06-30 to 2011-09-30 | money | quarterly_revenue | 114,424,000 United States dollar | superseded | [clm_0CB375426AF0](/claim/clm_0CB375426AF0.md) - 2011-06-30 to 2011-09-30 | money | total_assets | 1,763,100,000 United States dollar | superseded | [clm_6B7C068E138D](/claim/clm_6B7C068E138D.md) - 2011-06-30 to 2011-09-30 | money | total_equity | 307,549,000 United States dollar | superseded | [clm_1F567078AF69](/claim/clm_1F567078AF69.md) - 2011-07-29 to 2011-10-28 | money | shares_outstanding | 208,087,899 shares | superseded | [clm_47B306C70D65](/claim/clm_47B306C70D65.md) - 2011-09-30 to 2011-12-31 | money | cash_and_equivalents | 542,545,000 United States dollar | superseded | [clm_51A871DDB6C2](/claim/clm_51A871DDB6C2.md) - 2011-09-30 to 2012-03-31 | money | quarterly_net_income | 221,110,000 United States dollar | superseded | [clm_2E31B54439BF](/claim/clm_2E31B54439BF.md) - 2011-09-30 to 2012-03-31 | money | quarterly_operating_income | 215,707,000 United States dollar | superseded | [clm_B3AC75D212CF](/claim/clm_B3AC75D212CF.md) - 2011-09-30 to 2012-03-31 | money | quarterly_research_and_development | 189,052,000 United States dollar | superseded | [clm_B00D340EC942](/claim/clm_B00D340EC942.md) - 2011-09-30 to 2012-03-31 | money | quarterly_revenue | 659,200,000 United States dollar | superseded | [clm_AFFDEC5591E2](/claim/clm_AFFDEC5591E2.md) - 2011-09-30 to 2011-12-31 | money | total_assets | 2,091,998,000 United States dollar | superseded | [clm_0364D2508EA1](/claim/clm_0364D2508EA1.md) - 2011-09-30 to 2011-12-31 | money | total_equity | 579,762,000 United States dollar | superseded | [clm_56187F563316](/claim/clm_56187F563316.md) - 2011-10-28 to 2012-02-08 | money | shares_outstanding | 208,566,194 shares | superseded | [clm_AA7202AF1645](/claim/clm_AA7202AF1645.md) - 2011-12-31 to 2012-03-31 | money | cash_and_equivalents | 475,320,000 United States dollar | superseded | [clm_84EBB48920A6](/claim/clm_84EBB48920A6.md) - 2011-12-31 to 2012-12-31 | money | net_income | 29,574,000 United States dollar | superseded | [clm_D6D7CB158831](/claim/clm_D6D7CB158831.md) - 2011-12-31 to 2012-12-31 | money | operating_income | 113,820,000 United States dollar | superseded | [clm_E814D4173C5E](/claim/clm_E814D4173C5E.md) - 2011-12-31 to 2012-12-31 | money | research_and_development | 707,706,000 United States dollar | superseded | [clm_7FB96A1EC04F](/claim/clm_7FB96A1EC04F.md) - 2011-12-31 to 2012-12-31 | money | revenue | 1,410,626,000 United States dollar | superseded | [clm_EDAEC8A3D536](/claim/clm_EDAEC8A3D536.md) - 2011-12-31 to 2012-03-31 | money | total_assets | 2,204,280,000 United States dollar | superseded | [clm_15FE4534F8E1](/claim/clm_15FE4534F8E1.md) - 2011-12-31 to 2012-03-31 | money | total_equity | 786,843,000 United States dollar | superseded | [clm_46A87149904E](/claim/clm_46A87149904E.md) ## 2012 - 2012-02-08 to 2012-04-27 | money | shares_outstanding | 210,335,993 shares | superseded | [clm_E8ED2497AD7B](/claim/clm_E8ED2497AD7B.md) - 2012-03-31 to 2012-06-30 | money | cash_and_equivalents | 267,923,000 United States dollar | superseded | [clm_B1D95D9229AF](/claim/clm_B1D95D9229AF.md) - 2012-03-31 to 2012-06-30 | money | quarterly_net_income | 91,590,000 United States dollar | superseded | [clm_C0D5B06E732F](/claim/clm_C0D5B06E732F.md) - 2012-03-31 to 2012-06-30 | money | quarterly_operating_income | 91,649,000 United States dollar | superseded | [clm_85DA72CF3BE5](/claim/clm_85DA72CF3BE5.md) - 2012-03-31 to 2012-06-30 | money | quarterly_research_and_development | 196,371,000 United States dollar | superseded | [clm_CEDFEA389A43](/claim/clm_CEDFEA389A43.md) - 2012-03-31 to 2012-06-30 | money | quarterly_revenue | 438,737,000 United States dollar | superseded | [clm_D0A8C98B8F52](/claim/clm_D0A8C98B8F52.md) - 2012-03-31 to 2012-06-30 | money | total_assets | 2,345,843,000 United States dollar | superseded | [clm_A3EAB937180F](/claim/clm_A3EAB937180F.md) - 2012-03-31 to 2012-06-30 | money | total_equity | 930,498,000 United States dollar | superseded | [clm_7DA2AEFA0080](/claim/clm_7DA2AEFA0080.md) - 2012-04-27 to 2012-07-27 | money | shares_outstanding | 211,061,148 shares | superseded | [clm_78F55C9D6D48](/claim/clm_78F55C9D6D48.md) - 2012-06-30 to 2012-09-30 | money | cash_and_equivalents | 454,061,000 United States dollar | superseded | [clm_FC85126D5926](/claim/clm_FC85126D5926.md) - 2012-06-30 to 2012-09-30 | money | quarterly_net_income | -64,931,000 United States dollar | superseded | [clm_76A2F176E63C](/claim/clm_76A2F176E63C.md) - 2012-06-30 to 2012-09-30 | money | quarterly_operating_income | -10,770,000 United States dollar | superseded | [clm_0A5AAF6DC9F9](/claim/clm_0A5AAF6DC9F9.md) - 2012-06-30 to 2012-09-30 | money | quarterly_research_and_development | 196,544,000 United States dollar | superseded | [clm_87BBE0E23F91](/claim/clm_87BBE0E23F91.md) - 2012-06-30 to 2012-09-30 | money | quarterly_revenue | 418,305,000 United States dollar | superseded | [clm_EDB18FEAB098](/claim/clm_EDB18FEAB098.md) - 2012-06-30 to 2012-09-30 | money | total_assets | 2,604,856,000 United States dollar | superseded | [clm_D1DAC76653E3](/claim/clm_D1DAC76653E3.md) - 2012-06-30 to 2012-09-30 | money | total_equity | 1,037,773,000 United States dollar | superseded | [clm_72E671723425](/claim/clm_72E671723425.md) - 2012-07-27 to 2012-10-26 | money | shares_outstanding | 215,807,482 shares | superseded | [clm_F20A5D8DC03B](/claim/clm_F20A5D8DC03B.md) - 2012-09-30 to 2012-12-31 | money | cash_and_equivalents | 436,886,000 United States dollar | superseded | [clm_E50A47FF19A4](/claim/clm_E50A47FF19A4.md) - 2012-09-30 to 2013-03-31 | money | quarterly_net_income | -57,543,000 United States dollar | superseded | [clm_F8030CD50108](/claim/clm_F8030CD50108.md) - 2012-09-30 to 2013-03-31 | money | quarterly_operating_income | -1,071,000 United States dollar | superseded | [clm_C200AAD1B7D9](/claim/clm_C200AAD1B7D9.md) - 2012-09-30 to 2013-03-31 | money | quarterly_research_and_development | 200,161,000 United States dollar | superseded | [clm_440DD76F9BF9](/claim/clm_440DD76F9BF9.md) - 2012-09-30 to 2013-03-31 | money | quarterly_revenue | 336,006,000 United States dollar | superseded | [clm_8B3F25617388](/claim/clm_8B3F25617388.md) - 2012-09-30 to 2012-12-31 | money | total_assets | 2,718,823,000 United States dollar | superseded | [clm_68D80A12D2B9](/claim/clm_68D80A12D2B9.md) - 2012-09-30 to 2012-12-31 | money | total_equity | 1,027,733,000 United States dollar | superseded | [clm_DD677E25C8F6](/claim/clm_DD677E25C8F6.md) - 2012-10-26 to 2013-02-15 | money | shares_outstanding | 216,827,066 shares | superseded | [clm_70D8F6354992](/claim/clm_70D8F6354992.md) - 2012-12-31 to 2013-03-31 | money | cash_and_equivalents | 489,407,000 United States dollar | superseded | [clm_FCBF93D0B813](/claim/clm_FCBF93D0B813.md) - 2012-12-31 to 2013-12-31 | money | net_income | -107,032,000 United States dollar | superseded | [clm_117D40256E77](/claim/clm_117D40256E77.md) - 2012-12-31 to 2013-12-31 | money | operating_income | 2,332,000 United States dollar | superseded | [clm_4F9C4EE9CB90](/claim/clm_4F9C4EE9CB90.md) - 2012-12-31 to 2013-12-31 | money | research_and_development | 806,185,000 United States dollar | superseded | [clm_CA9105114287](/claim/clm_CA9105114287.md) - 2012-12-31 to 2013-12-31 | money | revenue | 1,527,042,000 United States dollar | superseded | [clm_1A11D785AD34](/claim/clm_1A11D785AD34.md) - 2012-12-31 to 2013-03-31 | money | total_assets | 2,759,288,000 United States dollar | superseded | [clm_16575A0C10F3](/claim/clm_16575A0C10F3.md) - 2012-12-31 to 2013-03-31 | money | total_equity | 999,180,000 United States dollar | superseded | [clm_2A4FE21B733E](/claim/clm_2A4FE21B733E.md) ## 2013 - 2013-02-15 to 2013-04-26 | money | shares_outstanding | 218,188,628 shares | superseded | [clm_C9B18373B83D](/claim/clm_C9B18373B83D.md) - 2013-03-31 to 2013-06-30 | money | cash_and_equivalents | 379,099,000 United States dollar | superseded | [clm_4285D9F06BA1](/claim/clm_4285D9F06BA1.md) - 2013-03-31 to 2013-06-30 | money | quarterly_net_income | -308,016,000 United States dollar | superseded | [clm_34EFC0C950B9](/claim/clm_34EFC0C950B9.md) - 2013-03-31 to 2013-06-30 | money | quarterly_operating_income | -438,288,000 United States dollar | superseded | [clm_140090973306](/claim/clm_140090973306.md) - 2013-03-31 to 2013-06-30 | money | quarterly_research_and_development | 218,095,000 United States dollar | superseded | [clm_74FB230D7BFA](/claim/clm_74FB230D7BFA.md) - 2013-03-31 to 2013-06-30 | money | quarterly_revenue | 328,368,000 United States dollar | superseded | [clm_7FF4DCB7FD4C](/claim/clm_7FF4DCB7FD4C.md) - 2013-03-31 to 2013-06-30 | money | total_assets | 2,392,234,000 United States dollar | superseded | [clm_2B5B93D6737A](/claim/clm_2B5B93D6737A.md) - 2013-03-31 to 2013-06-30 | money | total_equity | 746,115,000 United States dollar | superseded | [clm_066255CCD67E](/claim/clm_066255CCD67E.md) - 2013-04-26 to 2013-07-26 | money | shares_outstanding | 221,400,864 shares | superseded | [clm_F2071C89A470](/claim/clm_F2071C89A470.md) - 2013-06-30 to 2013-09-30 | money | cash_and_equivalents | 531,247,000 United States dollar | superseded | [clm_95893F39D81D](/claim/clm_95893F39D81D.md) - 2013-06-30 to 2013-09-30 | money | quarterly_net_income | -57,165,000 United States dollar | superseded | [clm_2152B7E19DEE](/claim/clm_2152B7E19DEE.md) - 2013-06-30 to 2013-09-30 | money | quarterly_operating_income | -56,933,000 United States dollar | superseded | [clm_802A10BA2903](/claim/clm_802A10BA2903.md) - 2013-06-30 to 2013-09-30 | money | quarterly_research_and_development | 222,455,000 United States dollar | superseded | [clm_246A631757AE](/claim/clm_246A631757AE.md) - 2013-06-30 to 2013-09-30 | money | quarterly_revenue | 310,750,000 United States dollar | superseded | [clm_FF8C09587BDA](/claim/clm_FF8C09587BDA.md) - 2013-06-30 to 2013-09-30 | money | total_assets | 2,584,329,000 United States dollar | superseded | [clm_13FE3C35A2BF](/claim/clm_13FE3C35A2BF.md) - 2013-06-30 to 2013-09-30 | money | total_equity | 1,322,453,000 United States dollar | superseded | [clm_D261B9E53F59](/claim/clm_D261B9E53F59.md) - 2013-07-26 to 2013-10-31 | money | shares_outstanding | 232,812,301 shares | superseded | [clm_BEFDB3212DCF](/claim/clm_BEFDB3212DCF.md) - 2013-09-30 to 2013-12-31 | money | cash_and_equivalents | 583,181,000 United States dollar | superseded | [clm_393B542CC9D8](/claim/clm_393B542CC9D8.md) - 2013-09-30 to 2014-03-31 | money | quarterly_net_income | -124,132,000 United States dollar | superseded | [clm_E100CA9B87CC](/claim/clm_E100CA9B87CC.md) - 2013-09-30 to 2014-03-31 | money | quarterly_operating_income | -134,065,000 United States dollar | superseded | [clm_31AFB2309D37](/claim/clm_31AFB2309D37.md) - 2013-09-30 to 2014-03-31 | money | quarterly_research_and_development | 228,624,000 United States dollar | superseded | [clm_4D0F0C1EE546](/claim/clm_4D0F0C1EE546.md) - 2013-09-30 to 2014-03-31 | money | quarterly_revenue | 221,700,000 United States dollar | superseded | [clm_48045D19FF6B](/claim/clm_48045D19FF6B.md) - 2013-09-30 to 2013-12-31 | money | total_assets | 2,582,748,000 United States dollar | superseded | [clm_4674F8E819AD](/claim/clm_4674F8E819AD.md) - 2013-09-30 to 2013-12-31 | money | total_equity | 1,264,888,000 United States dollar | superseded | [clm_6D0B6A2430B2](/claim/clm_6D0B6A2430B2.md) - 2013-10-31 to 2014-02-05 | money | shares_outstanding | 233,756,871 shares | superseded | [clm_EB4B38E18AF2](/claim/clm_EB4B38E18AF2.md) - 2013-12-31 to 2014-03-31 | money | cash_and_equivalents | 569,299,000 United States dollar | superseded | [clm_9BA598811A16](/claim/clm_9BA598811A16.md) - 2013-12-31 to 2014-12-31 | money | net_income | -445,028,000 United States dollar | superseded | [clm_59D5E0CC1F00](/claim/clm_59D5E0CC1F00.md) - 2013-12-31 to 2014-12-31 | money | operating_income | -903,448,000 United States dollar | superseded | [clm_A3A048BBF066](/claim/clm_A3A048BBF066.md) - 2013-12-31 to 2014-12-31 | money | research_and_development | 918,783,000 United States dollar | superseded | [clm_727E384A5333](/claim/clm_727E384A5333.md) - 2013-12-31 to 2014-12-31 | money | revenue | 1,211,975,000 United States dollar | superseded | [clm_B995587F5A51](/claim/clm_B995587F5A51.md) - 2013-12-31 to 2014-03-31 | money | total_assets | 2,319,041,000 United States dollar | superseded | [clm_8F39AD572FD3](/claim/clm_8F39AD572FD3.md) - 2013-12-31 to 2014-03-31 | money | total_equity | 1,356,405,000 United States dollar | superseded | [clm_260A5D665F9C](/claim/clm_260A5D665F9C.md) ## 2014 - 2014-02-05 to 2014-04-25 | money | shares_outstanding | 235,771,942 shares | superseded | [clm_E2A186C9E37B](/claim/clm_E2A186C9E37B.md) - 2014-03-31 to 2014-06-30 | money | cash_and_equivalents | 424,045,000 United States dollar | superseded | [clm_4CF2DBBF2865](/claim/clm_4CF2DBBF2865.md) - 2014-03-31 to 2014-06-30 | money | quarterly_net_income | -232,457,000 United States dollar | superseded | [clm_9DB52C5BBEAA](/claim/clm_9DB52C5BBEAA.md) - 2014-03-31 to 2014-06-30 | money | quarterly_operating_income | -216,388,000 United States dollar | superseded | [clm_4AA01F0AE5BB](/claim/clm_4AA01F0AE5BB.md) - 2014-03-31 to 2014-06-30 | money | quarterly_research_and_development | 238,963,000 United States dollar | superseded | [clm_4F43AE81E1E8](/claim/clm_4F43AE81E1E8.md) - 2014-03-31 to 2014-06-30 | money | quarterly_revenue | 118,451,000 United States dollar | superseded | [clm_70C273FE1AD2](/claim/clm_70C273FE1AD2.md) - 2014-03-31 to 2014-06-30 | money | total_assets | 2,197,108,000 United States dollar | superseded | [clm_1085DB3D0A82](/claim/clm_1085DB3D0A82.md) - 2014-03-31 to 2014-06-30 | money | total_equity | 1,230,878,000 United States dollar | superseded | [clm_9AE7AF8EC0D1](/claim/clm_9AE7AF8EC0D1.md) - 2014-04-25 to 2014-07-25 | money | shares_outstanding | 236,194,337 shares | superseded | [clm_D207B55FE5A6](/claim/clm_D207B55FE5A6.md) - 2014-06-30 to 2014-09-30 | money | cash_and_equivalents | 420,558,000 United States dollar | superseded | [clm_A8C0C28AF1BF](/claim/clm_A8C0C28AF1BF.md) - 2014-06-30 to 2014-09-30 | money | quarterly_net_income | -159,382,000 United States dollar | superseded | [clm_34EE023B80C3](/claim/clm_34EE023B80C3.md) - 2014-06-30 to 2014-09-30 | money | quarterly_operating_income | -180,835,000 United States dollar | superseded | [clm_F90C0CD0E0F7](/claim/clm_F90C0CD0E0F7.md) - 2014-06-30 to 2014-09-30 | money | quarterly_research_and_development | 224,780,000 United States dollar | superseded | [clm_D9114AAA14BA](/claim/clm_D9114AAA14BA.md) - 2014-06-30 to 2014-09-30 | money | quarterly_revenue | 138,421,000 United States dollar | superseded | [clm_52B14B1D462C](/claim/clm_52B14B1D462C.md) - 2014-06-30 to 2014-09-30 | money | total_assets | 2,117,820,000 United States dollar | superseded | [clm_F96409BD070A](/claim/clm_F96409BD070A.md) - 2014-06-30 to 2014-09-30 | money | total_equity | 1,172,269,000 United States dollar | superseded | [clm_46E7801D804E](/claim/clm_46E7801D804E.md) - 2014-07-25 to 2014-10-31 | money | shares_outstanding | 238,081,533 shares | superseded | [clm_8D7D5AA15F63](/claim/clm_8D7D5AA15F63.md) - 2014-09-30 to 2014-12-31 | money | cash_and_equivalents | 718,563,000 United States dollar | superseded | [clm_B60FF5975D9F](/claim/clm_B60FF5975D9F.md) - 2014-09-30 to 2015-03-31 | money | quarterly_net_income | -170,060,000 United States dollar | superseded | [clm_F0EB4C4B4423](/claim/clm_F0EB4C4B4423.md) - 2014-09-30 to 2015-03-31 | money | quarterly_operating_income | -142,203,000 United States dollar | superseded | [clm_230B3E2BC570](/claim/clm_230B3E2BC570.md) - 2014-09-30 to 2015-03-31 | money | quarterly_research_and_development | 190,939,000 United States dollar | superseded | [clm_411488F61069](/claim/clm_411488F61069.md) - 2014-09-30 to 2015-03-31 | money | quarterly_revenue | 178,987,000 United States dollar | superseded | [clm_E49939D6DEDB](/claim/clm_E49939D6DEDB.md) - 2014-09-30 to 2014-12-31 | money | total_assets | 2,406,086,000 United States dollar | superseded | [clm_6195F192CBDE](/claim/clm_6195F192CBDE.md) - 2014-09-30 to 2014-12-31 | money | total_equity | 1,155,905,000 United States dollar | superseded | [clm_81C9DAEE5D23](/claim/clm_81C9DAEE5D23.md) - 2014-10-31 to 2015-01-31 | money | shares_outstanding | 240,521,809 shares | superseded | [clm_479F66F00F16](/claim/clm_479F66F00F16.md) - 2014-12-31 to 2015-03-31 | money | cash_and_equivalents | 625,259,000 United States dollar | superseded | [clm_C9477D430932](/claim/clm_C9477D430932.md) - 2014-12-31 to 2015-12-31 | money | net_income | -738,555,000 United States dollar | superseded | [clm_E0C813E29FDB](/claim/clm_E0C813E29FDB.md) - 2014-12-31 to 2015-12-31 | money | operating_income | -692,412,000 United States dollar | superseded | [clm_729B31AEC767](/claim/clm_729B31AEC767.md) - 2014-12-31 to 2015-12-31 | money | research_and_development | 855,506,000 United States dollar | superseded | [clm_2F6A721A75E3](/claim/clm_2F6A721A75E3.md) - 2014-12-31 to 2015-12-31 | money | revenue | 580,415,000 United States dollar | superseded | [clm_76E972477DD6](/claim/clm_76E972477DD6.md) - 2014-12-31 to 2015-03-31 | money | total_assets | 2,334,679,000 United States dollar | superseded | [clm_34CC74560F05](/claim/clm_34CC74560F05.md) - 2014-12-31 to 2015-03-31 | money | total_equity | 1,075,006,000 United States dollar | superseded | [clm_16DE270CBEB7](/claim/clm_16DE270CBEB7.md) ## 2015 - 2015-01-31 to 2015-04-24 | money | shares_outstanding | 242,088,884 shares | superseded | [clm_4142294B3920](/claim/clm_4142294B3920.md) - 2015-03-31 to 2015-06-30 | money | cash_and_equivalents | 664,879,000 United States dollar | superseded | [clm_ECB58BC2FBDB](/claim/clm_ECB58BC2FBDB.md) - 2015-03-31 to 2015-06-30 | money | quarterly_net_income | -198,606,000 United States dollar | superseded | [clm_64459540A52F](/claim/clm_64459540A52F.md) - 2015-03-31 to 2015-06-30 | money | quarterly_operating_income | -171,985,000 United States dollar | superseded | [clm_3ADC1054C2B6](/claim/clm_3ADC1054C2B6.md) - 2015-03-31 to 2015-06-30 | money | quarterly_research_and_development | 215,599,000 United States dollar | superseded | [clm_2A57AC8A186B](/claim/clm_2A57AC8A186B.md) - 2015-03-31 to 2015-06-30 | money | quarterly_revenue | 138,509,000 United States dollar | superseded | [clm_72E202E696DB](/claim/clm_72E202E696DB.md) - 2015-03-31 to 2015-06-30 | money | total_assets | 2,165,827,000 United States dollar | superseded | [clm_D21E1EE854F6](/claim/clm_D21E1EE854F6.md) - 2015-03-31 to 2015-06-30 | money | total_equity | 976,458,000 United States dollar | superseded | [clm_33DE4ADFA95C](/claim/clm_33DE4ADFA95C.md) - 2015-04-24 to 2015-07-24 | money | shares_outstanding | 243,752,247 shares | superseded | [clm_F2E292BAD47A](/claim/clm_F2E292BAD47A.md) - 2015-06-30 to 2015-09-30 | money | cash_and_equivalents | 870,543,000 United States dollar | superseded | [clm_1EF267F21DD6](/claim/clm_1EF267F21DD6.md) - 2015-06-30 to 2015-09-30 | money | quarterly_net_income | -188,848,000 United States dollar | superseded | [clm_E074FD6EA019](/claim/clm_E074FD6EA019.md) - 2015-06-30 to 2015-09-30 | money | quarterly_operating_income | -171,164,000 United States dollar | superseded | [clm_00535EE0B591](/claim/clm_00535EE0B591.md) - 2015-06-30 to 2015-09-30 | money | quarterly_research_and_development | 223,858,000 United States dollar | superseded | [clm_03E4A3140826](/claim/clm_03E4A3140826.md) - 2015-06-30 to 2015-09-30 | money | quarterly_revenue | 166,076,000 United States dollar | superseded | [clm_26173C591341](/claim/clm_26173C591341.md) - 2015-06-30 to 2015-09-30 | money | total_assets | 2,374,073,000 United States dollar | superseded | [clm_82FAC17B63B7](/claim/clm_82FAC17B63B7.md) - 2015-06-30 to 2015-09-30 | money | total_equity | 894,964,000 United States dollar | superseded | [clm_12232D5A6B98](/claim/clm_12232D5A6B98.md) - 2015-07-24 to 2015-10-23 | money | shares_outstanding | 244,655,527 shares | superseded | [clm_74711F790F20](/claim/clm_74711F790F20.md) - 2015-09-30 to 2015-12-31 | money | cash_and_equivalents | 756,250,000 United States dollar | superseded | [clm_D372DE4FDD99](/claim/clm_D372DE4FDD99.md) - 2015-09-30 to 2016-03-31 | money | quarterly_net_income | -95,149,000 United States dollar | superseded | [clm_716BECC984E5](/claim/clm_716BECC984E5.md) - 2015-09-30 to 2016-03-31 | money | quarterly_operating_income | -70,026,000 United States dollar | superseded | [clm_A645F319F190](/claim/clm_A645F319F190.md) - 2015-09-30 to 2016-03-31 | money | quarterly_research_and_development | 246,284,000 United States dollar | superseded | [clm_6E79D9B514B1](/claim/clm_6E79D9B514B1.md) - 2015-09-30 to 2016-03-31 | money | quarterly_revenue | 309,816,000 United States dollar | superseded | [clm_86562BC405C6](/claim/clm_86562BC405C6.md) - 2015-09-30 to 2015-12-31 | money | total_assets | 2,433,993,000 United States dollar | superseded | [clm_60B4E50AFB70](/claim/clm_60B4E50AFB70.md) - 2015-09-30 to 2015-12-31 | money | total_equity | 922,147,000 United States dollar | superseded | [clm_979E4CDDAA4B](/claim/clm_979E4CDDAA4B.md) - 2015-10-23 to 2016-01-31 | money | shares_outstanding | 245,717,286 shares | superseded | [clm_A9C81118AB1C](/claim/clm_A9C81118AB1C.md) - 2015-12-31 to 2016-03-31 | money | cash_and_equivalents | 714,768,000 United States dollar | superseded | [clm_E053D1ED646F](/claim/clm_E053D1ED646F.md) - 2015-12-31 to 2016-12-31 | money | net_income | -556,334,000 United States dollar | superseded | [clm_3CC906E153DA](/claim/clm_3CC906E153DA.md) - 2015-12-31 to 2016-12-31 | money | operating_income | -466,879,000 United States dollar | superseded | [clm_B6F6CDFC9E0A](/claim/clm_B6F6CDFC9E0A.md) - 2015-12-31 to 2016-12-31 | money | research_and_development | 995,922,000 United States dollar | superseded | [clm_09536F600AFF](/claim/clm_09536F600AFF.md) - 2015-12-31 to 2016-12-31 | money | revenue | 1,032,336,000 United States dollar | superseded | [clm_B9A0D3A94E4B](/claim/clm_B9A0D3A94E4B.md) - 2015-12-31 to 2016-03-31 | money | total_assets | 2,498,875,000 United States dollar | superseded | [clm_1B7DAA0B3049](/claim/clm_1B7DAA0B3049.md) - 2015-12-31 to 2016-03-31 | money | total_equity | 939,967,000 United States dollar | superseded | [clm_F45B3CB0C752](/claim/clm_F45B3CB0C752.md) ## 2016 - 2016-01-31 to 2016-04-20 | money | shares_outstanding | 246,391,955 shares | superseded | [clm_E922A99A9EA6](/claim/clm_E922A99A9EA6.md) - 2016-03-31 to 2016-06-30 | money | cash_and_equivalents | 604,245,000 United States dollar | superseded | [clm_70FFDCCAA48B](/claim/clm_70FFDCCAA48B.md) - 2016-03-31 to 2016-06-30 | money | quarterly_net_income | -41,631,000 United States dollar | superseded | [clm_D76BCB337804](/claim/clm_D76BCB337804.md) - 2016-03-31 to 2016-06-30 | money | quarterly_operating_income | -14,330,000 United States dollar | superseded | [clm_6D374A34EDA7](/claim/clm_6D374A34EDA7.md) - 2016-03-31 to 2016-06-30 | money | quarterly_research_and_development | 255,860,000 United States dollar | superseded | [clm_08C42F082050](/claim/clm_08C42F082050.md) - 2016-03-31 to 2016-06-30 | money | quarterly_revenue | 398,080,000 United States dollar | superseded | [clm_D1405FE577D0](/claim/clm_D1405FE577D0.md) - 2016-03-31 to 2016-06-30 | money | total_assets | 2,487,906,000 United States dollar | superseded | [clm_1114776585A3](/claim/clm_1114776585A3.md) - 2016-03-31 to 2016-06-30 | money | total_equity | 957,079,000 United States dollar | superseded | [clm_AB61E3D00C03](/claim/clm_AB61E3D00C03.md) - 2016-04-20 to 2016-07-22 | money | shares_outstanding | 247,349,864 shares | superseded | [clm_184409A3DE47](/claim/clm_184409A3DE47.md) - 2016-06-30 to 2016-09-30 | money | cash_and_equivalents | 605,866,000 United States dollar | superseded | [clm_1C6CC599E968](/claim/clm_1C6CC599E968.md) - 2016-06-30 to 2016-09-30 | money | quarterly_net_income | -64,525,000 United States dollar | superseded | [clm_6A661CF6BB52](/claim/clm_6A661CF6BB52.md) - 2016-06-30 to 2016-09-30 | money | quarterly_operating_income | 3,353,000 United States dollar | superseded | [clm_2228EE6A3A62](/claim/clm_2228EE6A3A62.md) - 2016-06-30 to 2016-09-30 | money | quarterly_research_and_development | 271,008,000 United States dollar | superseded | [clm_C3B5C13564FF](/claim/clm_C3B5C13564FF.md) - 2016-06-30 to 2016-09-30 | money | quarterly_revenue | 431,608,000 United States dollar | superseded | [clm_3D46B58FF11A](/claim/clm_3D46B58FF11A.md) - 2016-06-30 to 2016-09-30 | money | total_assets | 2,548,982,000 United States dollar | superseded | [clm_0E60C94FDAC7](/claim/clm_0E60C94FDAC7.md) - 2016-06-30 to 2016-09-30 | money | total_equity | 981,354,000 United States dollar | superseded | [clm_E3F59624DB5A](/claim/clm_E3F59624DB5A.md) - 2016-07-22 to 2016-10-21 | money | shares_outstanding | 247,778,698 shares | superseded | [clm_AAFEE05A628C](/claim/clm_AAFEE05A628C.md) - 2016-09-30 to 2016-12-31 | money | cash_and_equivalents | 719,692,000 United States dollar | superseded | [clm_0B18EFEDD159](/claim/clm_0B18EFEDD159.md) - 2016-09-30 to 2017-03-31 | money | quarterly_net_income | -38,841,000 United States dollar | superseded | [clm_E8FAE6590B2B](/claim/clm_E8FAE6590B2B.md) - 2016-09-30 to 2017-03-31 | money | quarterly_operating_income | -18,727,000 United States dollar | superseded | [clm_FD2D956B4646](/claim/clm_FD2D956B4646.md) - 2016-09-30 to 2017-03-31 | money | quarterly_research_and_development | 272,370,000 United States dollar | superseded | [clm_77AD1FA686BE](/claim/clm_77AD1FA686BE.md) - 2016-09-30 to 2017-03-31 | money | quarterly_revenue | 413,783,000 United States dollar | superseded | [clm_882D250549DB](/claim/clm_882D250549DB.md) - 2016-09-30 to 2016-12-31 | money | total_assets | 2,609,641,000 United States dollar | superseded | [clm_3FA9F1E3CCFF](/claim/clm_3FA9F1E3CCFF.md) - 2016-09-30 to 2016-12-31 | money | total_equity | 1,021,546,000 United States dollar | superseded | [clm_26C5F13E4AFA](/claim/clm_26C5F13E4AFA.md) - 2016-10-21 to 2017-02-10 | money | shares_outstanding | 248,033,389 shares | superseded | [clm_E95980D51DAA](/claim/clm_E95980D51DAA.md) - 2016-12-31 to 2017-03-31 | money | cash_and_equivalents | 1,183,945,000 United States dollar | superseded | [clm_DD9DC904D715](/claim/clm_DD9DC904D715.md) - 2016-12-31 to 2017-12-31 | money | net_income | -112,052,000 United States dollar | superseded | [clm_2BC71558F3C9](/claim/clm_2BC71558F3C9.md) - 2016-12-31 to 2017-12-31 | money | operating_income | 9,936,000 United States dollar | superseded | [clm_C74861030CDE](/claim/clm_C74861030CDE.md) - 2016-12-31 to 2017-12-31 | money | research_and_development | 1,047,690,000 United States dollar | superseded | [clm_070B60D12935](/claim/clm_070B60D12935.md) - 2016-12-31 to 2017-12-31 | money | revenue | 1,702,177,000 United States dollar | superseded | [clm_3048F4177FBD](/claim/clm_3048F4177FBD.md) - 2016-12-31 to 2017-03-31 | money | total_assets | 2,896,787,000 United States dollar | superseded | [clm_39A46EBA4944](/claim/clm_39A46EBA4944.md) - 2016-12-31 to 2017-03-31 | money | total_equity | 1,156,582,000 United States dollar | superseded | [clm_A595BC2C5630](/claim/clm_A595BC2C5630.md) ## 2017 - 2017-02-10 to 2017-04-21 | money | shares_outstanding | 248,438,127 shares | superseded | [clm_56628A376B7F](/claim/clm_56628A376B7F.md) - 2017-03-31 to 2017-06-30 | money | cash_and_equivalents | 1,003,679,000 United States dollar | superseded | [clm_D5FCBE91D068](/claim/clm_D5FCBE91D068.md) - 2017-03-31 to 2017-06-30 | money | quarterly_net_income | 247,756,000 United States dollar | superseded | [clm_EB70297A6910](/claim/clm_EB70297A6910.md) - 2017-03-31 to 2017-06-30 | money | quarterly_operating_income | 270,842,000 United States dollar | superseded | [clm_37FE3BC729D9](/claim/clm_37FE3BC729D9.md) - 2017-03-31 to 2017-06-30 | money | quarterly_research_and_development | 273,563,000 United States dollar | superseded | [clm_90976FB1C473](/claim/clm_90976FB1C473.md) - 2017-03-31 to 2017-06-30 | money | quarterly_revenue | 714,718,000 United States dollar | superseded | [clm_7D8A031A80DB](/claim/clm_7D8A031A80DB.md) - 2017-03-31 to 2017-06-30 | money | total_assets | 2,946,703,000 United States dollar | superseded | [clm_218F213EBD5A](/claim/clm_218F213EBD5A.md) - 2017-03-31 to 2017-06-30 | money | total_equity | 1,500,008,000 United States dollar | superseded | [clm_B3CDEA1413F9](/claim/clm_B3CDEA1413F9.md) - 2017-04-21 to 2017-07-21 | money | shares_outstanding | 249,068,782 shares | superseded | [clm_AC9B824300B5](/claim/clm_AC9B824300B5.md) - 2017-06-30 to 2017-09-30 | money | cash_and_equivalents | 1,223,130,000 United States dollar | superseded | [clm_41E7A07E4BD9](/claim/clm_41E7A07E4BD9.md) - 2017-06-30 to 2017-09-30 | money | quarterly_net_income | 17,996,000 United States dollar | superseded | [clm_DAC478AD397E](/claim/clm_DAC478AD397E.md) - 2017-06-30 to 2017-09-30 | money | quarterly_operating_income | 52,707,000 United States dollar | superseded | [clm_4FCE9FD3FD98](/claim/clm_4FCE9FD3FD98.md) - 2017-06-30 to 2017-09-30 | money | quarterly_research_and_development | 289,451,000 United States dollar | superseded | [clm_B48FA71C174F](/claim/clm_B48FA71C174F.md) - 2017-06-30 to 2017-09-30 | money | quarterly_revenue | 544,135,000 United States dollar | superseded | [clm_F514C594F662](/claim/clm_F514C594F662.md) - 2017-06-30 to 2017-09-30 | money | total_assets | 3,285,594,000 United States dollar | superseded | [clm_E2CB6E1CCE2A](/claim/clm_E2CB6E1CCE2A.md) - 2017-06-30 to 2017-09-30 | money | total_equity | 1,671,273,000 United States dollar | superseded | [clm_8500F4409507](/claim/clm_8500F4409507.md) - 2017-07-21 to 2017-10-20 | money | shares_outstanding | 252,118,869 shares | superseded | [clm_096340916E85](/claim/clm_096340916E85.md) - 2017-09-30 to 2017-12-31 | money | cash_and_equivalents | 1,384,966,000 United States dollar | superseded | [clm_751B22F9EDDB](/claim/clm_751B22F9EDDB.md) - 2017-09-30 to 2018-03-31 | money | quarterly_net_income | -102,952,000 United States dollar | superseded | [clm_ED246483C6AB](/claim/clm_ED246483C6AB.md) - 2017-09-30 to 2018-03-31 | money | quarterly_operating_income | -326,043,000 United States dollar | superseded | [clm_1A65A038D644](/claim/clm_1A65A038D644.md) - 2017-09-30 to 2018-03-31 | money | quarterly_research_and_development | 454,947,000 United States dollar | superseded | [clm_5202D9005278](/claim/clm_5202D9005278.md) - 2017-09-30 to 2018-03-31 | money | quarterly_revenue | 578,165,000 United States dollar | superseded | [clm_933F26C8B388](/claim/clm_933F26C8B388.md) - 2017-09-30 to 2017-12-31 | money | total_assets | 3,198,325,000 United States dollar | superseded | [clm_72B030278F2C](/claim/clm_72B030278F2C.md) - 2017-09-30 to 2017-12-31 | money | total_equity | 1,791,077,000 United States dollar | superseded | [clm_2F530EB00B1B](/claim/clm_2F530EB00B1B.md) - 2017-10-20 to 2018-01-31 | money | shares_outstanding | 252,902,848 shares | superseded | [clm_40905FFA2E58](/claim/clm_40905FFA2E58.md) - 2017-12-31 to 2018-03-31 | money | cash_and_equivalents | 1,665,412,000 United States dollar | superseded | [clm_76C027BAF647](/claim/clm_76C027BAF647.md) - 2017-12-31 to 2018-12-31 | money | net_income | 263,484,000 United States dollar | superseded | [clm_EAA313C25D3D](/claim/clm_EAA313C25D3D.md) - 2017-12-31 to 2018-12-31 | money | operating_income | 123,243,000 United States dollar | superseded | [clm_03E98C0A4208](/claim/clm_03E98C0A4208.md) - 2017-12-31 to 2018-12-31 | money | research_and_development | 1,324,625,000 United States dollar | superseded | [clm_C5B2018B6129](/claim/clm_C5B2018B6129.md) - 2017-12-31 to 2018-12-31 | money | revenue | 2,488,652,000 United States dollar | superseded | [clm_88AABB0F5900](/claim/clm_88AABB0F5900.md) - 2017-12-31 to 2018-03-31 | money | total_assets | 3,546,014,000 United States dollar | superseded | [clm_0222BA7D9859](/claim/clm_0222BA7D9859.md) - 2017-12-31 to 2018-03-31 | money | total_equity | 2,028,579,000 United States dollar | superseded | [clm_A0081165ACC0](/claim/clm_A0081165ACC0.md) ## 2018 - 2018-01-31 to 2018-04-20 | money | shares_outstanding | 253,891,984 shares | superseded | [clm_0E283F15F605](/claim/clm_0E283F15F605.md) - 2018-03-31 to 2018-06-30 | money | cash_and_equivalents | 1,995,893,000 United States dollar | superseded | [clm_765AB85FE8D8](/claim/clm_765AB85FE8D8.md) - 2018-03-31 to 2018-06-30 | money | quarterly_net_income | 210,263,000 United States dollar | superseded | [clm_6AE5A6A85AD2](/claim/clm_6AE5A6A85AD2.md) - 2018-03-31 to 2018-06-30 | money | quarterly_operating_income | 128,901,000 United States dollar | superseded | [clm_A620E2C8FB71](/claim/clm_A620E2C8FB71.md) - 2018-03-31 to 2018-06-30 | money | quarterly_research_and_development | 310,553,000 United States dollar | superseded | [clm_0D1ACE4B2058](/claim/clm_0D1ACE4B2058.md) - 2018-03-31 to 2018-06-30 | money | quarterly_revenue | 640,799,000 United States dollar | superseded | [clm_66E56361C26E](/claim/clm_66E56361C26E.md) - 2018-03-31 to 2018-06-30 | money | total_assets | 3,952,974,000 United States dollar | superseded | [clm_4E19B710DABA](/claim/clm_4E19B710DABA.md) - 2018-03-31 to 2018-06-30 | money | total_equity | 2,401,056,000 United States dollar | superseded | [clm_A9DE66326560](/claim/clm_A9DE66326560.md) - 2018-04-20 to 2018-07-20 | money | shares_outstanding | 254,830,232 shares | superseded | [clm_D91AA7148A23](/claim/clm_D91AA7148A23.md) - 2018-06-30 to 2018-09-30 | money | cash_and_equivalents | 2,145,359,000 United States dollar | superseded | [clm_ADD73E1FB943](/claim/clm_ADD73E1FB943.md) - 2018-06-30 to 2018-09-30 | money | quarterly_net_income | 207,360,000 United States dollar | superseded | [clm_0E72F2D69F41](/claim/clm_0E72F2D69F41.md) - 2018-06-30 to 2018-09-30 | money | quarterly_operating_income | 172,878,000 United States dollar | superseded | [clm_61C96CE7DB96](/claim/clm_61C96CE7DB96.md) - 2018-06-30 to 2018-09-30 | money | quarterly_research_and_development | 337,532,000 United States dollar | superseded | [clm_75860C5404D3](/claim/clm_75860C5404D3.md) - 2018-06-30 to 2018-09-30 | money | quarterly_revenue | 752,157,000 United States dollar | superseded | [clm_7A545FD3F361](/claim/clm_7A545FD3F361.md) - 2018-06-30 to 2018-09-30 | money | total_assets | 4,335,386,000 United States dollar | superseded | [clm_30C87D2C1CBD](/claim/clm_30C87D2C1CBD.md) - 2018-06-30 to 2018-09-30 | money | total_equity | 2,686,228,000 United States dollar | superseded | [clm_BDF180B6AD97](/claim/clm_BDF180B6AD97.md) - 2018-07-20 to 2018-10-19 | money | shares_outstanding | 255,559,939 shares | superseded | [clm_A2CE75CC8517](/claim/clm_A2CE75CC8517.md) - 2018-09-30 to 2018-12-31 | money | cash_and_equivalents | 2,478,302,000 United States dollar | superseded | [clm_8F818D2E2F7B](/claim/clm_8F818D2E2F7B.md) - 2018-09-30 to 2019-03-31 | money | quarterly_net_income | 128,746,000 United States dollar | superseded | [clm_346AA350FC6D](/claim/clm_346AA350FC6D.md) - 2018-09-30 to 2019-03-31 | money | quarterly_operating_income | 205,649,000 United States dollar | superseded | [clm_D6C88602928F](/claim/clm_D6C88602928F.md) - 2018-09-30 to 2019-03-31 | money | quarterly_research_and_development | 330,510,000 United States dollar | superseded | [clm_C5F9C8D7CC95](/claim/clm_C5F9C8D7CC95.md) - 2018-09-30 to 2019-03-31 | money | quarterly_revenue | 784,535,000 United States dollar | superseded | [clm_8E2ABC809D39](/claim/clm_8E2ABC809D39.md) - 2018-09-30 to 2018-12-31 | money | total_assets | 4,620,840,000 United States dollar | superseded | [clm_C2CDDE4D143F](/claim/clm_C2CDDE4D143F.md) - 2018-09-30 to 2018-12-31 | money | total_equity | 2,906,116,000 United States dollar | superseded | [clm_815A8BEADE9D](/claim/clm_815A8BEADE9D.md) - 2018-10-19 to 2019-01-31 | money | shares_outstanding | 255,558,035 shares | superseded | [clm_D3864179769E](/claim/clm_D3864179769E.md) - 2018-12-31 to 2019-03-31 | money | cash_and_equivalents | 2,650,134,000 United States dollar | superseded | [clm_F36C4149DAE9](/claim/clm_F36C4149DAE9.md) - 2018-12-31 to 2019-12-31 | money | net_income | 2,096,896,000 United States dollar | superseded | [clm_D3A2B88BD1F9](/claim/clm_D3A2B88BD1F9.md) - 2018-12-31 to 2019-12-31 | money | operating_income | 635,150,000 United States dollar | superseded | [clm_30D3676BC4AE](/claim/clm_30D3676BC4AE.md) - 2018-12-31 to 2019-12-31 | money | research_and_development | 1,416,476,000 United States dollar | superseded | [clm_EF7099311C58](/claim/clm_EF7099311C58.md) - 2018-12-31 to 2019-12-31 | money | revenue | 3,047,597,000 United States dollar | superseded | [clm_9652C550528A](/claim/clm_9652C550528A.md) - 2018-12-31 to 2019-03-31 | money | total_equity | 4,435,203,000 United States dollar | superseded | [clm_38ED4A3E086C](/claim/clm_38ED4A3E086C.md) ## 2019 - 2019-01-01 to 2019-03-31 | money | total_assets | 6,261,958,000 United States dollar | superseded | [clm_E43D77EF5B44](/claim/clm_E43D77EF5B44.md) - 2019-01-31 to 2019-04-24 | money | shares_outstanding | 255,656,889 shares | superseded | [clm_2DB9804ECA5E](/claim/clm_2DB9804ECA5E.md) - 2019-03-31 to 2019-06-30 | money | cash_and_equivalents | 2,893,885,000 United States dollar | superseded | [clm_AA625CEFE3E2](/claim/clm_AA625CEFE3E2.md) - 2019-03-31 to 2019-06-30 | money | quarterly_net_income | 268,631,000 United States dollar | superseded | [clm_BFDA13517B9A](/claim/clm_BFDA13517B9A.md) - 2019-03-31 to 2019-06-30 | money | quarterly_operating_income | 276,808,000 United States dollar | superseded | [clm_6686B23D1227](/claim/clm_6686B23D1227.md) - 2019-03-31 to 2019-06-30 | money | quarterly_research_and_development | 339,490,000 United States dollar | superseded | [clm_1A5BF9CE8A15](/claim/clm_1A5BF9CE8A15.md) - 2019-03-31 to 2019-06-30 | money | quarterly_revenue | 858,435,000 United States dollar | superseded | [clm_3E7B3994881E](/claim/clm_3E7B3994881E.md) - 2019-03-31 to 2019-06-30 | money | total_assets | 6,543,114,000 United States dollar | superseded | [clm_3ECBB5B268CD](/claim/clm_3ECBB5B268CD.md) - 2019-03-31 to 2019-06-30 | money | total_equity | 4,723,313,000 United States dollar | superseded | [clm_19FEE797F4E7](/claim/clm_19FEE797F4E7.md) - 2019-04-24 to 2019-07-26 | money | shares_outstanding | 256,121,360 shares | superseded | [clm_9180A1508E64](/claim/clm_9180A1508E64.md) - 2019-06-30 to 2019-09-30 | money | cash_and_equivalents | 3,294,684,000 United States dollar | superseded | [clm_73E5227A4A27](/claim/clm_73E5227A4A27.md) - 2019-06-30 to 2019-09-30 | money | quarterly_net_income | 267,427,000 United States dollar | superseded | [clm_391AC2F64417](/claim/clm_391AC2F64417.md) - 2019-06-30 to 2019-09-30 | money | quarterly_operating_income | 269,960,000 United States dollar | superseded | [clm_3837B5FA4621](/claim/clm_3837B5FA4621.md) - 2019-06-30 to 2019-09-30 | money | quarterly_research_and_development | 379,091,000 United States dollar | superseded | [clm_6053DA9FFA3A](/claim/clm_6053DA9FFA3A.md) - 2019-06-30 to 2019-09-30 | money | quarterly_revenue | 941,293,000 United States dollar | superseded | [clm_CDABAE46C981](/claim/clm_CDABAE46C981.md) - 2019-06-30 to 2019-09-30 | money | total_assets | 7,033,471,000 United States dollar | superseded | [clm_0B97F438BFA4](/claim/clm_0B97F438BFA4.md) - 2019-06-30 to 2019-09-30 | money | total_equity | 5,069,965,000 United States dollar | superseded | [clm_DD7CA9ADDF1C](/claim/clm_DD7CA9ADDF1C.md) - 2019-07-26 to 2019-10-18 | money | shares_outstanding | 257,035,443 shares | superseded | [clm_1AA1A71F7141](/claim/clm_1AA1A71F7141.md) - 2019-09-30 to 2019-12-31 | money | cash_and_equivalents | 3,397,941,000 United States dollar | superseded | [clm_713E0D0A2043](/claim/clm_713E0D0A2043.md) - 2019-09-30 to 2020-03-31 | money | quarterly_net_income | 57,518,000 United States dollar | superseded | [clm_81C047352B0D](/claim/clm_81C047352B0D.md) - 2019-09-30 to 2020-03-31 | money | quarterly_operating_income | 99,333,000 United States dollar | superseded | [clm_63C6CFD02CA4](/claim/clm_63C6CFD02CA4.md) - 2019-09-30 to 2020-03-31 | money | quarterly_research_and_development | 555,948,000 United States dollar | superseded | [clm_E4FC8BA4267A](/claim/clm_E4FC8BA4267A.md) - 2019-09-30 to 2020-03-31 | money | quarterly_revenue | 949,828,000 United States dollar | superseded | [clm_01DE6C70A804](/claim/clm_01DE6C70A804.md) - 2019-09-30 to 2019-12-31 | money | total_assets | 7,514,553,000 United States dollar | superseded | [clm_606AE4761405](/claim/clm_606AE4761405.md) - 2019-09-30 to 2019-12-31 | money | total_equity | 5,253,394,000 United States dollar | superseded | [clm_DBBB2E7ADFB1](/claim/clm_DBBB2E7ADFB1.md) - 2019-10-18 to 2020-01-31 | money | shares_outstanding | 257,149,588 shares | superseded | [clm_F6BD01886FBB](/claim/clm_F6BD01886FBB.md) - 2019-12-31 to 2020-03-31 | money | cash_and_equivalents | 3,109,322,000 United States dollar | superseded | [clm_8D8808029B98](/claim/clm_8D8808029B98.md) - 2019-12-31 to 2020-12-31 | money | net_income | 1,176,810,000 United States dollar | superseded | [clm_FE5B5CF4FB84](/claim/clm_FE5B5CF4FB84.md) - 2019-12-31 to 2020-12-31 | money | operating_income | 1,197,566,000 United States dollar | superseded | [clm_05A793B89218](/claim/clm_05A793B89218.md) - 2019-12-31 to 2020-12-31 | money | research_and_development | 1,754,540,000 United States dollar | superseded | [clm_4875DCC74B8B](/claim/clm_4875DCC74B8B.md) - 2019-12-31 to 2020-12-31 | money | revenue | 4,162,821,000 United States dollar | superseded | [clm_98E5E59F6D9E](/claim/clm_98E5E59F6D9E.md) - 2019-12-31 to 2020-03-31 | money | total_assets | 8,318,465,000 United States dollar | superseded | [clm_8E39CFC66249](/claim/clm_8E39CFC66249.md) - 2019-12-31 to 2020-03-31 | money | total_equity | 6,085,200,000 United States dollar | superseded | [clm_2E4E3E5F618D](/claim/clm_2E4E3E5F618D.md) ## 2020 - 2020-01-31 to 2020-04-24 | money | shares_outstanding | 259,268,593 shares | superseded | [clm_B0DC25435A02](/claim/clm_B0DC25435A02.md) - 2020-03-31 to 2020-06-30 | money | cash_and_equivalents | 3,593,412,000 United States dollar | superseded | [clm_AC9CCBAF0908](/claim/clm_AC9CCBAF0908.md) - 2020-03-31 to 2020-06-30 | money | quarterly_net_income | 602,753,000 United States dollar | superseded | [clm_98EA8D3ED9D1](/claim/clm_98EA8D3ED9D1.md) - 2020-03-31 to 2020-06-30 | money | quarterly_operating_income | 720,224,000 United States dollar | superseded | [clm_EB1B0B642262](/claim/clm_EB1B0B642262.md) - 2020-03-31 to 2020-06-30 | money | quarterly_research_and_development | 448,528,000 United States dollar | superseded | [clm_5AE1EF5CC196](/claim/clm_5AE1EF5CC196.md) - 2020-03-31 to 2020-06-30 | money | quarterly_revenue | 1,515,107,000 United States dollar | superseded | [clm_ED12A2E330B4](/claim/clm_ED12A2E330B4.md) - 2020-03-31 to 2020-06-30 | money | total_assets | 8,893,201,000 United States dollar | superseded | [clm_C020ABBFE645](/claim/clm_C020ABBFE645.md) - 2020-03-31 to 2020-06-30 | money | total_equity | 6,461,654,000 United States dollar | superseded | [clm_C1525E494CB5](/claim/clm_C1525E494CB5.md) - 2020-04-24 to 2020-07-23 | money | shares_outstanding | 259,276,709 shares | superseded | [clm_987CBFB7A223](/claim/clm_987CBFB7A223.md) - 2020-06-30 to 2020-09-30 | money | cash_and_equivalents | 4,831,332,000 United States dollar | superseded | [clm_6915B8D4ABB5](/claim/clm_6915B8D4ABB5.md) - 2020-06-30 to 2020-09-30 | money | quarterly_net_income | 837,270,000 United States dollar | superseded | [clm_CBAB0AE654C4](/claim/clm_CBAB0AE654C4.md) - 2020-06-30 to 2020-09-30 | money | quarterly_operating_income | 718,033,000 United States dollar | superseded | [clm_FE5D60C65052](/claim/clm_FE5D60C65052.md) - 2020-06-30 to 2020-09-30 | money | quarterly_research_and_development | 420,928,000 United States dollar | superseded | [clm_92B502813AA4](/claim/clm_92B502813AA4.md) - 2020-06-30 to 2020-09-30 | money | quarterly_revenue | 1,524,485,000 United States dollar | superseded | [clm_EE20986F8F62](/claim/clm_EE20986F8F62.md) - 2020-06-30 to 2020-09-30 | money | total_assets | 10,216,367,000 United States dollar | superseded | [clm_194411381C8C](/claim/clm_194411381C8C.md) - 2020-06-30 to 2020-09-30 | money | total_equity | 7,519,242,000 United States dollar | superseded | [clm_BF61DD66F463](/claim/clm_BF61DD66F463.md) - 2020-07-23 to 2020-10-23 | money | shares_outstanding | 260,467,334 shares | superseded | [clm_9BAB61679F38](/claim/clm_9BAB61679F38.md) - 2020-09-30 to 2020-12-31 | money | cash_and_equivalents | 5,358,087,000 United States dollar | superseded | [clm_69B23FF91BEB](/claim/clm_69B23FF91BEB.md) - 2020-09-30 to 2021-03-31 | money | quarterly_net_income | 667,434,000 United States dollar | superseded | [clm_B82BAA2538E3](/claim/clm_B82BAA2538E3.md) - 2020-09-30 to 2021-03-31 | money | quarterly_operating_income | 672,241,000 United States dollar | superseded | [clm_4C3B1A02B828](/claim/clm_4C3B1A02B828.md) - 2020-09-30 to 2021-03-31 | money | quarterly_research_and_development | 493,497,000 United States dollar | superseded | [clm_8C6FF5B4800E](/claim/clm_8C6FF5B4800E.md) - 2020-09-30 to 2021-03-31 | money | quarterly_revenue | 1,538,271,000 United States dollar | superseded | [clm_D38659C12AE8](/claim/clm_D38659C12AE8.md) - 2020-09-30 to 2020-12-31 | money | total_assets | 11,301,633,000 United States dollar | superseded | [clm_12837A3657DA](/claim/clm_12837A3657DA.md) - 2020-09-30 to 2020-12-31 | money | total_equity | 8,133,473,000 United States dollar | superseded | [clm_9E3B341B6DD1](/claim/clm_9E3B341B6DD1.md) - 2020-10-23 to 2021-01-31 | money | shares_outstanding | 260,037,894 shares | superseded | [clm_5240C50AF834](/claim/clm_5240C50AF834.md) - 2020-12-31 to 2021-03-31 | money | cash_and_equivalents | 5,988,187,000 United States dollar | superseded | [clm_0A0A75CC866D](/claim/clm_0A0A75CC866D.md) - 2020-12-31 to 2021-12-31 | money | net_income | 2,711,647,000 United States dollar | superseded | [clm_79102BFD0743](/claim/clm_79102BFD0743.md) - 2020-12-31 to 2021-12-31 | money | operating_income | 2,856,290,000 United States dollar | superseded | [clm_227207794AE5](/claim/clm_227207794AE5.md) - 2020-12-31 to 2021-12-31 | money | research_and_development | 1,829,537,000 United States dollar | superseded | [clm_4E727A17F6D8](/claim/clm_4E727A17F6D8.md) - 2020-12-31 to 2021-12-31 | money | revenue | 6,205,683,000 United States dollar | superseded | [clm_710D5BB40195](/claim/clm_710D5BB40195.md) - 2020-12-31 to 2021-03-31 | money | total_assets | 11,751,808,000 United States dollar | superseded | [clm_C7952DDAD12A](/claim/clm_C7952DDAD12A.md) - 2020-12-31 to 2021-03-31 | money | total_equity | 8,686,800,000 United States dollar | superseded | [clm_12C888060D24](/claim/clm_12C888060D24.md) ## 2021 - 2021-01-31 to 2021-04-22 | money | shares_outstanding | 259,960,062 shares | superseded | [clm_DB51B55830F5](/claim/clm_DB51B55830F5.md) - 2021-03-31 to 2021-06-30 | money | cash_and_equivalents | 6,304,330,000 United States dollar | superseded | [clm_E30E4F36DF29](/claim/clm_E30E4F36DF29.md) - 2021-03-31 to 2021-06-30 | money | quarterly_net_income | 653,138,000 United States dollar | superseded | [clm_D8AA2809B20A](/claim/clm_D8AA2809B20A.md) - 2021-03-31 to 2021-06-30 | money | quarterly_operating_income | 887,826,000 United States dollar | superseded | [clm_C212C614D9A6](/claim/clm_C212C614D9A6.md) - 2021-03-31 to 2021-06-30 | money | quarterly_research_and_development | 455,973,000 United States dollar | superseded | [clm_E4E066FF8D42](/claim/clm_E4E066FF8D42.md) - 2021-03-31 to 2021-06-30 | money | quarterly_revenue | 1,724,305,000 United States dollar | superseded | [clm_05E33637AD96](/claim/clm_05E33637AD96.md) - 2021-03-31 to 2021-06-30 | money | total_assets | 12,115,059,000 United States dollar | superseded | [clm_934E3BFFB8E5](/claim/clm_934E3BFFB8E5.md) - 2021-03-31 to 2021-06-30 | money | total_equity | 8,980,254,000 United States dollar | superseded | [clm_A498CCC0EE53](/claim/clm_A498CCC0EE53.md) - 2021-04-22 to 2021-07-23 | money | shares_outstanding | 258,865,671 shares | superseded | [clm_BF1FDA0B7CEF](/claim/clm_BF1FDA0B7CEF.md) - 2021-06-30 to 2021-09-30 | money | cash_and_equivalents | 6,063,678,000 United States dollar | superseded | [clm_84A1E26AC5B8](/claim/clm_84A1E26AC5B8.md) - 2021-06-30 to 2021-09-30 | money | quarterly_net_income | 66,924,000 United States dollar | superseded | [clm_4F89C70F30F6](/claim/clm_4F89C70F30F6.md) - 2021-06-30 to 2021-09-30 | money | quarterly_operating_income | -37,961,000 United States dollar | superseded | [clm_1F15DBA70DE0](/claim/clm_1F15DBA70DE0.md) - 2021-06-30 to 2021-09-30 | money | quarterly_research_and_development | 1,407,090,000 United States dollar | superseded | [clm_DC884CD97A0D](/claim/clm_DC884CD97A0D.md) - 2021-06-30 to 2021-09-30 | money | quarterly_revenue | 1,793,370,000 United States dollar | superseded | [clm_BA95AEDBE337](/claim/clm_BA95AEDBE337.md) - 2021-06-30 to 2021-09-30 | money | total_assets | 12,221,686,000 United States dollar | superseded | [clm_E7CFB5DF9247](/claim/clm_E7CFB5DF9247.md) - 2021-06-30 to 2021-09-30 | money | total_equity | 9,196,396,000 United States dollar | superseded | [clm_A83B0E7547F1](/claim/clm_A83B0E7547F1.md) - 2021-07-23 to 2021-10-29 | money | shares_outstanding | 259,428,394 shares | superseded | [clm_B929FA328F8E](/claim/clm_B929FA328F8E.md) - 2021-09-30 to 2021-12-31 | money | cash_and_equivalents | 6,275,698,000 United States dollar | superseded | [clm_CC12F522D151](/claim/clm_CC12F522D151.md) - 2021-09-30 to 2022-03-31 | money | quarterly_net_income | 851,928,000 United States dollar | superseded | [clm_94A2F9498133](/claim/clm_94A2F9498133.md) - 2021-09-30 to 2022-03-31 | money | quarterly_operating_income | 1,054,512,000 United States dollar | superseded | [clm_1CB49C635F67](/claim/clm_1CB49C635F67.md) - 2021-09-30 to 2022-03-31 | money | quarterly_research_and_development | 493,751,000 United States dollar | superseded | [clm_86D501AB2F5C](/claim/clm_86D501AB2F5C.md) - 2021-09-30 to 2022-03-31 | money | quarterly_revenue | 1,984,164,000 United States dollar | superseded | [clm_6BB57BAD5620](/claim/clm_6BB57BAD5620.md) - 2021-09-30 to 2021-12-31 | money | total_assets | 12,618,745,000 United States dollar | superseded | [clm_90424EB08D26](/claim/clm_90424EB08D26.md) - 2021-09-30 to 2021-12-31 | money | total_equity | 9,530,708,000 United States dollar | superseded | [clm_B630EC176E52](/claim/clm_B630EC176E52.md) - 2021-10-29 to 2022-01-31 | money | shares_outstanding | 254,251,938 shares | superseded | [clm_02288182B0BB](/claim/clm_02288182B0BB.md) - 2021-12-31 to 2022-03-31 | money | cash_and_equivalents | 6,795,000,000 United States dollar | superseded | [clm_A982731934E0](/claim/clm_A982731934E0.md) - 2021-12-31 to 2022-12-31 | money | net_income | 2,342,100,000 United States dollar | superseded | [clm_F3A2B9FC81F1](/claim/clm_F3A2B9FC81F1.md) - 2021-12-31 to 2022-12-31 | money | operating_income | 2,782,100,000 United States dollar | superseded | [clm_DB3896AB26E8](/claim/clm_DB3896AB26E8.md) - 2021-12-31 | money | research_and_development | 3,051,100,000 United States dollar | valid | [clm_A31B2D7AAD7A](/claim/clm_A31B2D7AAD7A.md) - 2021-12-31 to 2022-12-31 | money | revenue | 7,574,400,000 United States dollar | superseded | [clm_054958897891](/claim/clm_054958897891.md) - 2021-12-31 to 2022-03-31 | money | total_assets | 13,432,500,000 United States dollar | superseded | [clm_883D81B67C94](/claim/clm_883D81B67C94.md) - 2021-12-31 to 2022-03-31 | money | total_equity | 10,100,000,000 United States dollar | superseded | [clm_1E5426FCEFF5](/claim/clm_1E5426FCEFF5.md) ## 2022 - 2022-01-31 to 2022-04-29 | money | shares_outstanding | 254,576,691 shares | superseded | [clm_075B175EC177](/claim/clm_075B175EC177.md) - 2022-03-31 to 2022-06-30 | money | cash_and_equivalents | 7,600,100,000 United States dollar | superseded | [clm_AAF7A5074870](/claim/clm_AAF7A5074870.md) - 2022-03-31 to 2022-06-30 | money | quarterly_net_income | 762,100,000 United States dollar | superseded | [clm_243DDF043D62](/claim/clm_243DDF043D62.md) - 2022-03-31 to 2022-06-30 | money | quarterly_operating_income | 1,040,900,000 United States dollar | superseded | [clm_2A24B9B7FC69](/claim/clm_2A24B9B7FC69.md) - 2022-03-31 | money | quarterly_research_and_development | 603,100,000 United States dollar | valid | [clm_CF81367A05A7](/claim/clm_CF81367A05A7.md) - 2022-03-31 to 2022-06-30 | money | quarterly_revenue | 2,097,500,000 United States dollar | superseded | [clm_47EA232B8F9C](/claim/clm_47EA232B8F9C.md) - 2022-03-31 to 2022-06-30 | money | total_assets | 14,256,100,000 United States dollar | superseded | [clm_AEC6A8645EE2](/claim/clm_AEC6A8645EE2.md) - 2022-03-31 to 2022-06-30 | money | total_equity | 10,907,000,000 United States dollar | superseded | [clm_318FD2D6E763](/claim/clm_318FD2D6E763.md) - 2022-04-29 to 2022-07-29 | money | shares_outstanding | 255,755,961 shares | superseded | [clm_CD985C968363](/claim/clm_CD985C968363.md) - 2022-06-30 to 2022-09-30 | money | cash_and_equivalents | 8,702,200,000 United States dollar | superseded | [clm_2EBAE376F4A3](/claim/clm_2EBAE376F4A3.md) - 2022-06-30 to 2022-09-30 | money | quarterly_net_income | 810,500,000 United States dollar | superseded | [clm_203BAAA42E77](/claim/clm_203BAAA42E77.md) - 2022-06-30 to 2022-09-30 | money | quarterly_operating_income | 1,106,300,000 United States dollar | superseded | [clm_5B1D0BBCD832](/claim/clm_5B1D0BBCD832.md) - 2022-06-30 to 2022-09-30 | money | quarterly_revenue | 2,196,200,000 United States dollar | superseded | [clm_F084A45C1F3A](/claim/clm_F084A45C1F3A.md) - 2022-06-30 to 2022-09-30 | money | total_assets | 15,582,200,000 United States dollar | superseded | [clm_09D1A8C06700](/claim/clm_09D1A8C06700.md) - 2022-06-30 to 2022-09-30 | money | total_equity | 11,933,500,000 United States dollar | superseded | [clm_53E6658C91B5](/claim/clm_53E6658C91B5.md) - 2022-07-29 to 2022-10-21 | money | shares_outstanding | 256,459,482 shares | superseded | [clm_09C3E31B05ED](/claim/clm_09C3E31B05ED.md) - 2022-09-30 to 2022-12-31 | money | cash_and_equivalents | 9,171,500,000 United States dollar | superseded | [clm_0BD6127815F8](/claim/clm_0BD6127815F8.md) - 2022-09-30 to 2023-03-31 | money | quarterly_net_income | 930,500,000 United States dollar | superseded | [clm_4BC06D9A5911](/claim/clm_4BC06D9A5911.md) - 2022-09-30 to 2023-03-31 | money | quarterly_operating_income | 1,126,700,000 United States dollar | superseded | [clm_E6727C1C16C9](/claim/clm_E6727C1C16C9.md) - 2022-09-30 to 2023-03-31 | money | quarterly_revenue | 2,334,300,000 United States dollar | superseded | [clm_A07370340B6C](/claim/clm_A07370340B6C.md) - 2022-09-30 to 2022-12-31 | money | total_assets | 16,706,400,000 United States dollar | superseded | [clm_2C70611C367D](/claim/clm_2C70611C367D.md) - 2022-09-30 to 2022-12-31 | money | total_equity | 13,029,600,000 United States dollar | superseded | [clm_61A9104D30AD](/claim/clm_61A9104D30AD.md) - 2022-10-21 to 2023-01-31 | money | shares_outstanding | 256,691,452 shares | superseded | [clm_07E003F90843](/claim/clm_07E003F90843.md) - 2022-12-31 to 2023-03-31 | money | cash_and_equivalents | 10,504,000,000 United States dollar | superseded | [clm_63A9B4EA0EFC](/claim/clm_63A9B4EA0EFC.md) - 2022-12-31 to 2023-12-31 | money | net_income | 3,322,000,000 United States dollar | superseded | [clm_1B7C3640D846](/claim/clm_1B7C3640D846.md) - 2022-12-31 to 2023-12-31 | money | operating_income | 4,307,400,000 United States dollar | superseded | [clm_EA4DD24E67F5](/claim/clm_EA4DD24E67F5.md) - 2022-12-31 to 2023-12-31 | money | revenue | 8,930,700,000 United States dollar | superseded | [clm_AC7CF3A293FF](/claim/clm_AC7CF3A293FF.md) - 2022-12-31 to 2023-03-31 | money | total_assets | 18,150,900,000 United States dollar | superseded | [clm_9F22DDDCD1C9](/claim/clm_9F22DDDCD1C9.md) - 2022-12-31 to 2023-03-31 | money | total_equity | 13,912,700,000 United States dollar | superseded | [clm_6D580D76E517](/claim/clm_6D580D76E517.md) ## 2023 - 2023-01-31 to 2023-04-25 | money | shares_outstanding | 257,091,441 shares | superseded | [clm_3C5FD882584C](/claim/clm_3C5FD882584C.md) - 2023-03-31 to 2023-06-30 | money | cash_and_equivalents | 9,289,900,000 United States dollar | superseded | [clm_DA9B9E142C37](/claim/clm_DA9B9E142C37.md) - 2023-03-31 to 2023-06-30 | money | quarterly_net_income | 699,800,000 United States dollar | superseded | [clm_CCC1584CC243](/claim/clm_CCC1584CC243.md) - 2023-03-31 to 2023-06-30 | money | quarterly_operating_income | 779,000,000 United States dollar | superseded | [clm_4D9C12DA102E](/claim/clm_4D9C12DA102E.md) - 2023-03-31 to 2023-06-30 | money | quarterly_revenue | 2,374,800,000 United States dollar | superseded | [clm_56F24DCACD81](/claim/clm_56F24DCACD81.md) - 2023-03-31 to 2023-06-30 | money | total_assets | 18,974,200,000 United States dollar | superseded | [clm_FF4FA49D5268](/claim/clm_FF4FA49D5268.md) - 2023-03-31 to 2023-06-30 | money | total_equity | 14,432,300,000 United States dollar | superseded | [clm_259DCABF6218](/claim/clm_259DCABF6218.md) - 2023-04-25 to 2023-07-31 | money | shares_outstanding | 257,551,600 shares | superseded | [clm_D7E4C28F5ECB](/claim/clm_D7E4C28F5ECB.md) - 2023-06-30 to 2023-09-30 | money | cash_and_equivalents | 10,151,100,000 United States dollar | superseded | [clm_D4ECC6686864](/claim/clm_D4ECC6686864.md) - 2023-06-30 to 2023-09-30 | money | quarterly_net_income | 915,700,000 United States dollar | superseded | [clm_87BE0FC8B08C](/claim/clm_87BE0FC8B08C.md) - 2023-06-30 to 2023-09-30 | money | quarterly_operating_income | 1,026,400,000 United States dollar | superseded | [clm_641582E9BBA4](/claim/clm_641582E9BBA4.md) - 2023-06-30 to 2023-09-30 | money | quarterly_revenue | 2,493,200,000 United States dollar | superseded | [clm_12CF2E7419A7](/claim/clm_12CF2E7419A7.md) - 2023-06-30 to 2023-09-30 | money | total_assets | 20,349,200,000 United States dollar | superseded | [clm_351DD5011D1D](/claim/clm_351DD5011D1D.md) - 2023-06-30 to 2023-09-30 | money | total_equity | 15,470,200,000 United States dollar | superseded | [clm_B62228AD3B5C](/claim/clm_B62228AD3B5C.md) - 2023-07-31 to 2023-10-31 | money | shares_outstanding | 258,094,815 shares | superseded | [clm_AF5A88F5634C](/claim/clm_AF5A88F5634C.md) - 2023-09-30 to 2023-12-31 | money | cash_and_equivalents | 11,110,200,000 United States dollar | superseded | [clm_3876937046B3](/claim/clm_3876937046B3.md) - 2023-09-30 to 2024-03-31 | money | quarterly_net_income | 1,035,300,000 United States dollar | superseded | [clm_78BFE90ACA99](/claim/clm_78BFE90ACA99.md) - 2023-09-30 to 2024-03-31 | money | quarterly_operating_income | 1,038,100,000 United States dollar | superseded | [clm_BE04B4442DA0](/claim/clm_BE04B4442DA0.md) - 2023-09-30 to 2024-03-31 | money | quarterly_revenue | 2,483,500,000 United States dollar | superseded | [clm_25F0B0F08F89](/claim/clm_25F0B0F08F89.md) - 2023-09-30 to 2023-12-31 | money | total_assets | 21,726,200,000 United States dollar | superseded | [clm_9193F0BF1A10](/claim/clm_9193F0BF1A10.md) - 2023-09-30 to 2023-12-31 | money | total_equity | 16,512,800,000 United States dollar | superseded | [clm_7E2CD975D5FB](/claim/clm_7E2CD975D5FB.md) - 2023-10-31 to 2024-02-09 | money | shares_outstanding | 257,683,184 shares | superseded | [clm_63DBD5A352EB](/claim/clm_63DBD5A352EB.md) - 2023-12-31 to 2024-03-31 | money | cash_and_equivalents | 10,369,100,000 United States dollar | superseded | [clm_CEBE7B1AF903](/claim/clm_CEBE7B1AF903.md) - 2023-12-31 to 2024-12-31 | money | net_income | 3,619,600,000 United States dollar | superseded | [clm_DD75AE2A6FF1](/claim/clm_DD75AE2A6FF1.md) - 2023-12-31 to 2024-12-31 | money | operating_income | 3,832,000,000 United States dollar | superseded | [clm_EDF03CE5BDB7](/claim/clm_EDF03CE5BDB7.md) - 2023-12-31 to 2024-12-31 | money | revenue | 9,869,200,000 United States dollar | superseded | [clm_6755CB60586A](/claim/clm_6755CB60586A.md) - 2023-12-31 to 2024-03-31 | money | total_assets | 22,730,200,000 United States dollar | superseded | [clm_4295FD965DBB](/claim/clm_4295FD965DBB.md) - 2023-12-31 to 2024-03-31 | money | total_equity | 17,580,400,000 United States dollar | superseded | [clm_89548106AA99](/claim/clm_89548106AA99.md) ## 2024 - 2024-02-09 to 2024-04-30 | money | shares_outstanding | 258,307,816 shares | superseded | [clm_1BAB99487696](/claim/clm_1BAB99487696.md) - 2024-03-31 to 2024-06-30 | money | cash_and_equivalents | 9,158,000,000 United States dollar | superseded | [clm_BA38CFEB0E56](/claim/clm_BA38CFEB0E56.md) - 2024-03-31 to 2024-06-30 | money | quarterly_net_income | 1,099,600,000 United States dollar | superseded | [clm_33B55A456707](/claim/clm_33B55A456707.md) - 2024-03-31 to 2024-06-30 | money | quarterly_operating_income | 1,139,500,000 United States dollar | superseded | [clm_472C99A37BC6](/claim/clm_472C99A37BC6.md) - 2024-03-31 to 2024-06-30 | money | quarterly_revenue | 2,690,600,000 United States dollar | superseded | [clm_40945582F02C](/claim/clm_40945582F02C.md) - 2024-03-31 to 2024-06-30 | money | total_assets | 23,917,400,000 United States dollar | superseded | [clm_E4FE15D6C00A](/claim/clm_E4FE15D6C00A.md) - 2024-03-31 to 2024-06-30 | money | total_equity | 18,546,600,000 United States dollar | superseded | [clm_3F0C247C527A](/claim/clm_3F0C247C527A.md) - 2024-04-10 | money | agreement | Alpine Immune Sciences, Inc. | valid | [clm_4B154EA0AEAE](/claim/clm_4B154EA0AEAE.md) - 2024-04-30 to 2024-07-31 | money | shares_outstanding | 258,053,387 shares | superseded | [clm_7CB6DBDB3720](/claim/clm_7CB6DBDB3720.md) - 2024-06-30 to 2024-09-30 | money | cash_and_equivalents | 4,580,100,000 United States dollar | superseded | [clm_C4593DB240D3](/claim/clm_C4593DB240D3.md) - 2024-06-30 to 2024-09-30 | money | quarterly_net_income | -3,593,600,000 United States dollar | superseded | [clm_B131D7103BCE](/claim/clm_B131D7103BCE.md) - 2024-06-30 to 2024-09-30 | money | quarterly_operating_income | -3,514,700,000 United States dollar | superseded | [clm_3C97D5DB5816](/claim/clm_3C97D5DB5816.md) - 2024-06-30 to 2024-09-30 | money | quarterly_revenue | 2,645,600,000 United States dollar | superseded | [clm_99B3D838F073](/claim/clm_99B3D838F073.md) - 2024-06-30 to 2024-09-30 | money | total_assets | 20,132,100,000 United States dollar | superseded | [clm_91183B1230B5](/claim/clm_91183B1230B5.md) - 2024-06-30 to 2024-09-30 | money | total_equity | 14,774,700,000 United States dollar | superseded | [clm_D1FB9551C69B](/claim/clm_D1FB9551C69B.md) - 2024-07-31 to 2024-10-31 | money | shares_outstanding | 258,102,203 shares | superseded | [clm_2E5075D7DBE3](/claim/clm_2E5075D7DBE3.md) - 2024-09-30 to 2024-12-31 | money | cash_and_equivalents | 5,239,200,000 United States dollar | superseded | [clm_17107958B9E8](/claim/clm_17107958B9E8.md) - 2024-09-30 to 2025-03-31 | money | quarterly_net_income | 1,045,400,000 United States dollar | superseded | [clm_E844FD7AD190](/claim/clm_E844FD7AD190.md) - 2024-09-30 to 2025-03-31 | money | quarterly_operating_income | 1,116,300,000 United States dollar | superseded | [clm_8EC7750600BF](/claim/clm_8EC7750600BF.md) - 2024-09-30 to 2025-03-31 | money | quarterly_revenue | 2,771,900,000 United States dollar | superseded | [clm_85558B741195](/claim/clm_85558B741195.md) - 2024-09-30 to 2024-12-31 | money | total_assets | 22,240,200,000 United States dollar | superseded | [clm_6D94781B6A40](/claim/clm_6D94781B6A40.md) - 2024-09-30 to 2024-12-31 | money | total_equity | 15,630,900,000 United States dollar | superseded | [clm_00AA213A3D85](/claim/clm_00AA213A3D85.md) - 2024-10-31 to 2025-02-07 | money | shares_outstanding | 257,529,290 shares | superseded | [clm_CDAE1063FD1E](/claim/clm_CDAE1063FD1E.md) - 2024-12-31 to 2025-03-31 | money | cash_and_equivalents | 4,569,600,000 United States dollar | superseded | [clm_7036AF53899D](/claim/clm_7036AF53899D.md) - 2024-12-31 to 2025-12-31 | money | net_income | -535,600,000 United States dollar | superseded | [clm_B3A7B0C585DF](/claim/clm_B3A7B0C585DF.md) - 2024-12-31 to 2025-12-31 | money | operating_income | -232,900,000 United States dollar | superseded | [clm_33A4466539E6](/claim/clm_33A4466539E6.md) - 2024-12-31 to 2025-12-31 | money | revenue | 11,020,100,000 United States dollar | superseded | [clm_9011721F7C0D](/claim/clm_9011721F7C0D.md) - 2024-12-31 to 2025-03-31 | money | total_assets | 22,533,200,000 United States dollar | superseded | [clm_F4271585E734](/claim/clm_F4271585E734.md) - 2024-12-31 to 2025-03-31 | money | total_equity | 16,409,600,000 United States dollar | superseded | [clm_D2246EF67C62](/claim/clm_D2246EF67C62.md) ## 2025 - 2025-02-07 to 2025-04-30 | money | shares_outstanding | 256,789,869 shares | superseded | [clm_30424A529FF7](/claim/clm_30424A529FF7.md) - 2025-03-31 to 2025-06-30 | money | cash_and_equivalents | 4,674,700,000 United States dollar | superseded | [clm_D421BB040AD7](/claim/clm_D421BB040AD7.md) - 2025-03-31 to 2025-06-30 | money | quarterly_net_income | 646,300,000 United States dollar | superseded | [clm_EDC8CDDAA243](/claim/clm_EDC8CDDAA243.md) - 2025-03-31 to 2025-06-30 | money | quarterly_operating_income | 630,100,000 United States dollar | superseded | [clm_2C985FE30E22](/claim/clm_2C985FE30E22.md) - 2025-03-31 to 2025-06-30 | money | quarterly_revenue | 2,770,200,000 United States dollar | superseded | [clm_1EC0DE7E99A1](/claim/clm_1EC0DE7E99A1.md) - 2025-03-31 to 2025-06-30 | money | total_assets | 22,880,500,000 United States dollar | superseded | [clm_AE9230AA7FE8](/claim/clm_AE9230AA7FE8.md) - 2025-03-31 to 2025-06-30 | money | total_equity | 16,496,300,000 United States dollar | superseded | [clm_030CF6670A5D](/claim/clm_030CF6670A5D.md) - 2025-04-30 to 2025-07-31 | money | shares_outstanding | 256,797,187 shares | superseded | [clm_7659E4652BD8](/claim/clm_7659E4652BD8.md) - 2025-06-30 to 2025-09-30 | money | cash_and_equivalents | 4,972,200,000 United States dollar | superseded | [clm_3F4C3A8A99D1](/claim/clm_3F4C3A8A99D1.md) - 2025-06-30 to 2025-09-30 | money | quarterly_net_income | 1,032,900,000 United States dollar | superseded | [clm_C2590A2F1C6C](/claim/clm_C2590A2F1C6C.md) - 2025-06-30 to 2025-09-30 | money | quarterly_operating_income | 1,151,100,000 United States dollar | superseded | [clm_E417E8C56F51](/claim/clm_E417E8C56F51.md) - 2025-06-30 to 2025-09-30 | money | quarterly_revenue | 2,964,700,000 United States dollar | superseded | [clm_9B7DD75E016B](/claim/clm_9B7DD75E016B.md) - 2025-06-30 to 2025-09-30 | money | total_assets | 24,036,700,000 United States dollar | superseded | [clm_68305CEE2495](/claim/clm_68305CEE2495.md) - 2025-06-30 to 2025-09-30 | money | total_equity | 17,175,400,000 United States dollar | superseded | [clm_D44D3849A57A](/claim/clm_D44D3849A57A.md) - 2025-07-31 to 2025-10-31 | money | shares_outstanding | 256,390,651 shares | superseded | [clm_ABBFFDB9DFAC](/claim/clm_ABBFFDB9DFAC.md) - 2025-09-30 to 2025-12-31 | money | cash_and_equivalents | 4,939,600,000 United States dollar | superseded | [clm_2FB43E38D7CC](/claim/clm_2FB43E38D7CC.md) - 2025-09-30 to 2026-03-31 | money | quarterly_net_income | 1,082,900,000 United States dollar | superseded | [clm_2FE795B3AF8B](/claim/clm_2FE795B3AF8B.md) - 2025-09-30 to 2026-03-31 | money | quarterly_operating_income | 1,186,200,000 United States dollar | superseded | [clm_7EF8A5505C22](/claim/clm_7EF8A5505C22.md) - 2025-09-30 to 2026-03-31 | money | quarterly_revenue | 3,076,400,000 United States dollar | superseded | [clm_8AB184162D82](/claim/clm_8AB184162D82.md) - 2025-09-30 to 2025-12-31 | money | total_assets | 24,862,300,000 United States dollar | superseded | [clm_D95598CEB876](/claim/clm_D95598CEB876.md) - 2025-09-30 to 2025-12-31 | money | total_equity | 17,318,800,000 United States dollar | superseded | [clm_1E5EC8CA7B8E](/claim/clm_1E5EC8CA7B8E.md) - 2025-10-31 to 2026-02-06 | money | shares_outstanding | 253,718,831 shares | superseded | [clm_663C199EF289](/claim/clm_663C199EF289.md) - 2025-12-31 to 2026-03-31 | money | cash_and_equivalents | 5,084,800,000 United States dollar | superseded | [clm_B4475729CD2A](/claim/clm_B4475729CD2A.md) - 2025-12-31 | money | net_income | 3,953,200,000 United States dollar | valid | [clm_406C31565DD9](/claim/clm_406C31565DD9.md) - 2025-12-31 | money | operating_income | 4,173,300,000 United States dollar | valid | [clm_08B6F6FEE28A](/claim/clm_08B6F6FEE28A.md) - 2025-12-31 | money | revenue | 12,001,300,000 United States dollar | valid | [clm_B151EC07FDAE](/claim/clm_B151EC07FDAE.md) - 2025-12-31 to 2026-03-31 | money | total_assets | 25,643,000,000 United States dollar | superseded | [clm_0090178AE4A5](/claim/clm_0090178AE4A5.md) - 2025-12-31 to 2026-03-31 | money | total_equity | 18,665,800,000 United States dollar | superseded | [clm_335F6E7CE9CE](/claim/clm_335F6E7CE9CE.md) ## 2026 - 2026-02-06 to 2026-04-30 | money | shares_outstanding | 254,034,190 shares | superseded | [clm_B7B98F7F000A](/claim/clm_B7B98F7F000A.md) - 2026-03-31 to 2026-06-30 | money | cash_and_equivalents | 5,492,900,000 United States dollar | superseded | [clm_379D75861ABB](/claim/clm_379D75861ABB.md) - 2026-03-31 to 2026-06-30 | money | quarterly_net_income | 1,031,400,000 United States dollar | superseded | [clm_58ABF4712193](/claim/clm_58ABF4712193.md) - 2026-03-31 to 2026-06-30 | money | quarterly_operating_income | 1,138,100,000 United States dollar | superseded | [clm_B8F364B1BB32](/claim/clm_B8F364B1BB32.md) - 2026-03-31 to 2026-06-30 | money | quarterly_revenue | 2,986,900,000 United States dollar | superseded | [clm_78B1FE0A2ECC](/claim/clm_78B1FE0A2ECC.md) - 2026-03-31 to 2026-06-30 | money | total_assets | 26,484,400,000 United States dollar | superseded | [clm_263F86EB65D1](/claim/clm_263F86EB65D1.md) - 2026-03-31 to 2026-06-30 | money | total_equity | 19,361,900,000 United States dollar | superseded | [clm_0F975664C00F](/claim/clm_0F975664C00F.md) - 2026-04-30 to 2026-07-31 | money | shares_outstanding | 253,805,417 shares | superseded | [clm_EA3BCAE7F8D0](/claim/clm_EA3BCAE7F8D0.md) - 2026-06-30 to 2026-09-30 | money | cash_and_equivalents | 6,143,500,000 United States dollar | superseded | [clm_0DE5C5FBB098](/claim/clm_0DE5C5FBB098.md) - 2026-06-30 to 2026-09-30 | money | quarterly_net_income | 1,099,800,000 United States dollar | superseded | [clm_5C5F8DB6F575](/claim/clm_5C5F8DB6F575.md) - 2026-06-30 to 2026-09-30 | money | quarterly_operating_income | 1,246,900,000 United States dollar | superseded | [clm_3B40C30B5BFE](/claim/clm_3B40C30B5BFE.md) - 2026-06-30 to 2026-09-30 | money | quarterly_revenue | 3,333,900,000 United States dollar | superseded | [clm_600A80B3AFE0](/claim/clm_600A80B3AFE0.md) - 2026-06-30 to 2026-09-30 | money | total_assets | 27,423,300,000 United States dollar | superseded | [clm_0B039E70EB86](/claim/clm_0B039E70EB86.md) - 2026-06-30 to 2026-09-30 | money | total_equity | 20,247,900,000 United States dollar | superseded | [clm_DDD2C596A0EC](/claim/clm_DDD2C596A0EC.md) - 2026-07-06 | money | agreement | Crinetics Pharmaceuticals, Inc. | valid | [clm_14EDB54D4A3B](/claim/clm_14EDB54D4A3B.md) - 2026-07-31 to 2026-10-31 | money | shares_outstanding | 253,460,924 shares | superseded | [clm_10753153913F](/claim/clm_10753153913F.md) - 2026-09-30 | money | cash_and_equivalents | 4,979,300,000 United States dollar | valid | [clm_40B40C0D43E5](/claim/clm_40B40C0D43E5.md) - 2026-09-30 | money | quarterly_net_income | 653,600,000 United States dollar | valid | [clm_466B90DBA1DE](/claim/clm_466B90DBA1DE.md) - 2026-09-30 | money | quarterly_operating_income | 712,900,000 United States dollar | valid | [clm_60BA65E99F72](/claim/clm_60BA65E99F72.md) - 2026-09-30 | money | quarterly_revenue | 3,440,800,000 United States dollar | valid | [clm_30E62BBC7C14](/claim/clm_30E62BBC7C14.md) - 2026-09-30 | money | total_assets | 32,736,300,000 United States dollar | valid | [clm_E8F64842EB2A](/claim/clm_E8F64842EB2A.md) - 2026-09-30 | money | total_equity | 20,907,400,000 United States dollar | valid | [clm_088E22D9B313](/claim/clm_088E22D9B313.md) - 2026-10-31 | money | shares_outstanding | 253,537,674 shares | valid | [clm_41CC1CCC4C8A](/claim/clm_41CC1CCC4C8A.md) --- AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.